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PREFACE
INTRODUCTION
Assisted Reproduction Technologies (ART) have been developed to treat infertility since
1790, when the first case of artificial insemination was performed. Since then, multiple and
dramatic advances have been made in the field of infertility research through the employment of
a variety of species; enabling people, whom without the use of these techniques, would not be
capable of reproducing. While the development of techniques to overcome infertility has been at
the forefront of reproductive research, investigation into the causes of infertility have also been,
and continue to be, equally as important as the remedies. It is well established that one major
contributor to female infertility is maternal age.

According to the Society for Assisted

Reproductive Technology (SART) statistics for 2007, oocyte retrievals in women <35yrs had a
43.1% live birth rate, while women 41-42yrs of age had a 14.3% live birth rate. Furthermore, the
average number of embryos per transfer was 2.2 in the <35yr age group and increased to 3.1 in
the 41-42yr age group, indicating that there is a decline in either oocyte or embryo quality with
age as well. While maternal age is known and can be a fairly reliable indicator of fertility;
oocyte and embryo quality contribute significantly to fertility as well, but are much more
difficult to determine. Oocyte quality is generally assessed by appearance and meiotic stage of
the oocyte at the time of collection and insemination. There are few guidelines that aid in
discriminating a competent from a non-competent oocyte and the process is subjective and
heavily dependent upon the embryologists’ skill and expertise. Embryo quality is more defined
in that there is an expected, timely progression of cell division and development through
preimplantation. It is reasonably simple to identify poor or bad embryos based upon morphology
and embryonic arrest during the cleavage stages; however, it remains difficult to identify a high
quality embryo based upon anything besides development rate and morphological quality score.
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Because of poor predictive value of embryo morphology, virtually all human ART clinics
practice multiple embryo transfers, which while increasing pregnancy and live birth rates, also
result in multiple births which can lead to pre and perinatal complications. Techniques such as
preimplantation genetic diagnosis (PGD) have been developed in attempts to remedy this
problem, however the results have been unreliable and the procedure is detrimental to the
embryo. Due to the fact that there are currently no reliable, objective ways to determine oocyte,
and even embryo, quality, it is imperative to ascertain methods to measure oocyte quality that
will improve selection of oocytes and embryos in ART clinics and increase pregnancy success
rates. These methods are only possible with a more complete understanding of the cellular and
molecular properties of oocytes and preimplantation embryos. A key component of all cells,
including oocytes and embryos, is the mitochondrion, which produces energy and maintains its
own DNA for encoding proteins necessary for energy production. Defects in either the proteins
responsible for energy production, the mitochondrial DNA (mtDNA) genome, or other
contributing factors can lead to loss of oocyte competence (failed fertilization) and embryo
quality (embryonic arrest, incompetent placentas, pregnancy loss). Unquestioningly, human
oocytes and the embryos derived from them would be the optimal material to use for performing
studies on oocyte quality and embryo development. However, practical and ethical constraints
prevent the use of human material for intensive, potentially terminal studies; thus, compelling
researchers to find and use suitable animal models instead. It is important that studies are
conducted with animals closely related to humans due to the wide diversity in cellular, molecular
and endocrine mechanisms used by different mammals in their reproductive strategies. The nonhuman primate (NHP) is the most befitting animal model for human reproduction due to
evolutionary closeness and the dramatic similarities in reproductive function and preimplantation
development.

Furthermore, because studies in human preimplantation development are
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restricted to the use of discarded oocytes from infertility clinics, the use of the NHP has
established the rhesus macaque as an excellent research model for human reproduction due to the
availability of normal, viable oocytes and embryos from fertile animals. Therefore, the overall
goals of this study were to evaluate mitochondria in NHP oocytes and embryos and to determine
how mtDNA mutations and mitochondrial function affect oocyte and embryo quality.
Specific Aim 1.1: To determine if the rhesus macaque can be utilized as a clinically
translational model for mitochondrial mutations identified in human IVF.
Specific Aim 1.2: To determine if the rate of mitochondrial mutations in rhesus macaque
oocytes and IVF produced embryos is increased due to gonadotrophin stimulation. A high
proportion of presumably normal oocytes give rise to developmentally incompetent embryos in
human IVF programs. Pre-implantation embryos generated by IVF show high frequencies of
abnormal development and early demise. A direct relationship between mitochondrial mutations
in oocytes and embryos and reproductive success has not been demonstrated; however, it is
generally assumed that there must be a sufficient number of functional mitochondrial genomes in
the embryo in order for it to develop and implant successfully. A mitochondrial mutation that
has been described in human oocytes and embryos is termed the “common deletion" or
ǻmtDNA4977. The reason for this mutation is currently unknown, however, an important
question is whether or not this deletion is caused by gonadotrophin stimulation. In order to
determine this, employment of the rhesus macaque as a clinically translational model is vital.
Specific Aim 2: Due to the frequency of the rhesus mtDNA common mutation in
gonadotrophin stimulated, rhesus macaque MII oocytes and IVP embryos, we hypothesize
that the common mutation will also be present in embryonic stem (ES) cells derived from
IVP produced embryos. We propose that the presence of numerous mtDNA deletions and
point mutations may actually reflect the quality of affected oocytes or primate ES cells lines.
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Primate ES cell lines may harbor mutant mtDNA that may further accumulate during cell
culture, and thus have consequences for long-term viability.
Specific Aim 3.1: To determine if the presence of mutations in the mtDNA control region,
as well as the mitochondrial polymerase, PolG, are associated with aging in the rhesus
macaque.
Specific Aim 3.2: To determine if in the presence of mutations in the mtDNA control region
are associated with meiotic failure in oocytes. In order to understand the significance of
mutations within the mtDNA genome, it is imperative to examine the region of the genome that
controls OXPHOS, replication and transcription. In addition to investigating the occurrence of
mutations in the mtDNA control region, we can determine if aging is a cause of mtDNA damage
as well identifying mutations that may be associated with failure of oocytes to mature to
metaphase II, enabling them to be fertilized.
Specific Aim 4: To determine if gonadotrophin stimulation efficiency and oocyte and
embryo quality can be improved through optimization of gonadotrophin stimulation
protocols.
Our laboratory has been working with the Caribbean Primate Research Center (CPRC)
for approximately 4 years in an effort to establish a reputable rhesus macaque IVF program using
the CPRC as a resource to provide high quality rhesus macaque oocytes, embryos and sperm. In
order to obtain rhesus macaque reproductive material of the highest quality, we tested three
modifications to the previously established gonadotrophin stimulation protocols.
Specific Aim 5.1: To determine if expression levels of genes controlling mitochondrial
dynamics are correlated to the failure of oocytes to resume meiosis.
Specific Aim 5.2: To determine if expression levels of genes controlling mitochondrial
dynamics are correlated to important preimplantation development time points.
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Interest in the mitochondrion and its role in the preimplantation mammalian embryo has
had a recent resurgence and it is understood that mitochondria undergo a variety of speciesspecific reorganizations during early preimplantation development. It is possible that the
localization of mitochondria in rhesus zygotes is a result of mitochondria undergoing fusion and
fission processes during preimplantation resulting in the microtubule network guiding the
mitochondria to their pronuclear location. Our lab has recently found that monkey oocytes have
an abundance of gene involved in the control of mitochondrial fusion, fission, movement and
replication. Therefore we speculate that mitochondrial trafficking is important for fusion and
fission mechanisms and may impact oocyte and embryo quality.
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CHAPTER 1
BACKGROUND AND SIGNIFICANCE
Oogenesis and Preimplantation Development
Oogenesis begins early in fetal development with the formation of primordial germ cells
(PGCs) which populate the fetal ovary. PGCs migrate along the hind gut during gestation to the
region adjacent to the mesonephros that becomes the genital ridge. PGCs are the sole source of
adult germ cells and once established in the developing ovary are referred to as oogonia.
Oogonia undergo several rounds of mitotic division over a period of several months until shortly
before birth, when meiosis is initiated. The primary oocytes progress through prophase I of the
first meiotic division before arresting at the diplotene stage. Diplotene oocytes are characterized
by diffused chromosomes surrounded by an intact nuclear membrane known as the germinal
vesicle (GV). With the resumption of meiosis, which occurs shortly after puberty, the interphase
chromatin condenses, the germinal vesicle membrane breaks down (GVBD), the spindles form
and chromosomes segregate. Extrusion of the first polar body marks the completion of the first
meiotic division. Oocytes then arrest again at metaphase II (MII). Completion of the second
meiotic division only occurs after fertilization and the extrusion of the second polar body. The
interaction of maternal and paternal pronuclei at syngamy is characterized by tight association of
both male and female pronuclear envelopes with close alignment of the nucleoli. In humans and
non-human primates, pronuclear membrane breakdown and commencement of the first mitotic
division ensues without actual fusion of the pronuclear envelopes, as is seen in a multitude of
other species (reviewed by (Levron et al., 1995).
Mitochondria and Reproduction
Mitochondria are considered entirely maternally inherited.

Although sperm carries

paternal mitochondria into the oocyte at fertilization, they are normally eliminated in early
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embryonic development by ubiquitin-tagging of the sperm surface. During the first half of fetal
development, mitochondria number around 10 in each premigratory PGC and increase to
approximately 200 in each original oogonium. Mitochondria then increase exponentially until
the diplotene stage of meiosis where they arrest. At birth, there are approximately two million
oocytes and each immature primordial oocyte contains about 6000 mitochondria (Jansen and
Burton, 2004; Shoubridge and Wai, 2007). Once puberty is reached, primordial follicles contain
oocytes arrested at the GV stage of development. Upon fertilization, during mitosis, mtDNA
synthesis and mitochondrial replication are inhibited as cleavage divides the mitochondria from
the fertilized oocyte among the daughter cells of the developing embryo.

This process

progressively reduces the mtDNA copy number per cell, or blastomere in the embryo, from the
0.5–5 million found in the oocyte at ovulation to approximately 10 per cell by the time
gastrulation begins. This process establishes a genetic bottleneck of mtDNA. The mitochondrial
bottleneck theory states that a limited number of mtDNAs (1-200) are the only mtDNAs selected
to undergo replication. These genetic founder mtDNAs replicate to give rise to almost all the
100,000 mtDNAs in mature MII oocytes (Jenuth et al., 1996). Typically, prior to mtDNA
replication, if oocytes contain a small percentage of mtDNAs with rearrangements, then random
selection of a limited number of founder mtDNAs would likely select normal mtDNAs for
replication.

At this point, the literature varies significantly about both the number of

mitochondria in each GV oocyte and the number of mtDNA copies per mitochondria. Upon
resumption of meiosis and during maturation, cytoplasmic growth of oocytes recruited for
ovulation indicates that mitochondrial numbers have increased, and in some species, i.e. NHP
and porcine (Gibson et al., 2005; Spikings et al., 2007) mtDNA replication occurs, increasing the
mtDNA copy number from GV to MII. This replication event does not appear to occur in the
mouse.
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Mitochondrial Function
Mitochondria are traditionally known as the powerhouses of the cell; the primary source
of ATP production. While this is true, the mitochondrion is an infinitely more complicated and
interesting organelle. The mitochondrion, which evolved from an oxidative Į-proteo-bacterium,
approximately 2 billion years, ago joined forces with a glycolytic motile cell evolving into what
we know currently as a eukaryotic cell. Over approximately 1.2 billion years a symbiotic
relationship evolved in which the mitochondrion became specialized in energy production and
the nucleus-cytosol became the driving force behind structure. As this relationship evolved
further, essentially all genetic function from the mitochondrion (~1500 genes) became part of the
chromosomal nuclear DNA. However, the mitochondrial genome did not disappear completely
and continues to retain the core subunits of the enzyme complexes of mitochondrial oxidative
phosphorylation (OXPHOS) (Wallace, 2008). Thirteen polypeptide-encoding genes, 2 rRNA
genes and 22 tRNA genes, all essential to OXPHOS, remain encoded by the mitochondrial
genome, rendering the mitochondrial DNA (mtDNA) genome essential to energy production and
cell function. Mitochondria generate energy through the electron transport complexes (ETC) by
oxidizing hydrogen with oxygen to generate heat and ATP.

Two electrons are passed

sequentially, either from NADH+H+ to complex I (NADH dehydrogenase) or from succinate to
complex II (succinate dehydrogenase), to ubiquinone (coenzyme Q) to give ubisemiquinone
(CoQH) and then ubiquinol (CoQH2).

Ubiquinol transfers its electrons to complex III

(cytochrome c oxidoreductase), which transfers them to cytochrome c. From cytochrome c, the
electrons ow to complex IV (cytochrome c oxidase, COX) and then to 1/2 O2 to give H2O. The
energy released from the ETC is used to pump protons out of the mitochondrial inner membrane
through complexes I, III, and IV, creating an electrochemical gradient. The potential energy
stored in the inner membrane is coupled to ATP synthesis by complex V (ATP synthase). As
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protons ow back into the matrix through a proton channel in complex V, ADP and Pi are
bound, condensed, and released as ATP. Matrix ATP is then exchanged for cytosolic ADP by
the adenine nucleotide translocator (ANT). As a by-product of OXPHOS, mitochondria generate
reactive oxygen species (ROS), in the forms of O2- (superoxide anion radical), H2O2 (hydrogen
peroxide) and OH (hydroxyl radical). Superoxide anion can be converted to hydrogen peroxide
which can then be converted to highly reactive hydroxyl radicals, rendering mitochondria key
targets for oxidative damage (reviewed by (Wallace, 2005).

H2O2, in conjunction with

superoxide anion, can damage cells by allowing the most reactive metabolite, OH, to form via
superoxide dismutase (SOD) and the Haber-Weiss reaction (Halliwell, 1989).
Because gametes and embryos require energy, which is produced by the conversion of
ADP to ATP via glycolysis and OXPHOS; a process by which O2 is intrinsic through its role as
an electron acceptor, O2-, H2O2 and OH have been well established as factors of oxidative stress
in in vitro culture systems. The production of excessive amounts of intracellular ROS during in
vitro embryo culture is thought to disrupt metabolic activity and is therefore detrimental to
embryo development (Guerin et al., 2001). The concentration of oxygen at which embryos are
cultured has shown to be a key factor in regulating OXPHOS and ROS production in several
species including bovine (Nagao et al., 1994), mouse (Goto et al., 1993) and human (Catt and
Henman, 2000; Dumoulin et al., 1999).

Furthermore, reduced O2 concentration that more

closely resembles physiological O2 results in higher blastocyst rates in mice (Dumoulin et al.,
1999), sheep (Bernardi et al., 1996) and bovine (Lonergan et al., 1999). In mammals, ovulation,
fertilization, and early embryo development occur in the oviduct. Embryos then migrate to the
uterus, where implantation occurs.

Oviductal O2 concentration is dramatically lower than

atmospheric concentration (Mastroianni and Jones, 1965) with the uterus maintaining an even
lower O2 concentration than that of the oviduct (Fischer and Bavister, 1993). Thus there is a
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decreasing O2 concentration gradient that embryos encounter as they progress through the
reproductive tract. Traditionally, in vitro culture systems employed 5% CO2 in atmospheric air
(approximately 20% O2). Studies in the last two decades have shown that culture of embryos
under an O2 concentration more closely resembling that of the oviduct (5% O2) result in
increased embryonic viability (Dumoulin et al., 1999), decreased H2O2 production and DNA
fragmentation (Kitagawa et al., 2004) and significantly increased pregnancy and birth rates as
well as blastocyst rate and quality (Waldenstrom et al., 2009).
In addition to energy production, mitochondria are key regulators of apoptosis.
Apoptosis can be initiated through the activation of the mitochondrial permeability transition
pore (mtPTP) in response to energy deficiency, increased oxidative stress, excessive calcium,
and other factors. A complete understanding of the mtPTP remains to be elucidated, however it
is thought to be composed of the inner membrane ANT, the outer membrane voltage-dependent
anion channel (VDAC), Bax, Bcl2, and cyclophilin D. When the mtPTP opens, membrane
potential decreases and ions equilibrate between the matrix and cytosol, causing a phenomenon
called mitochondrial outer membrane permeabilization (MOMP) and subsequent swelling of the
mitochondria. This results in the release of the contents of the mitochondrial inner membrane
space (cell death promoting factors such as cytochrome c) into the cytosol. Upon release,
cytochrome c activates factors which downstream activate caspases that propagate and execute
apoptosis.
The mitochondrial theory of aging (or the oxidative stress theory) holds that oxidative
damage to the mtDNA genome can lead to DNA strand breaks, deletions and mutations and
subsequent dysfunction of the respiratory chain. The most current version of this theory by
(Sohal and Weindruch, 1996) states that
“a chronic state of oxidative stress exists in cells of aerobic organisms even under
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normal physiological conditions because of an imbalance of pro-oxidants and
antioxidants. This imbalance results in a steady-state accumulation of oxidative
damage in a variety of macromolecules. Oxidative damage increases during
aging, which results in a progressive loss in the functional efficiency of various
cellular processes.”
Mitochondrial DNA is much more susceptible to ROS damage than nuclear DNA due to
its proximity to the site of ROS production, as well as the lack of histones and the limited repair
function of mtDNA. It is well established that as the proportion of mutated mtDNA increases,
the energetic output of the mitochondria subsequently declines, ROS production increases, and
the propensity for apoptosis increases, leading to loss of tissue function (Wallace, 2005).
Despite decades of research in support of the mitochondrial theory of aging, the exact
connection between aging and mitochondria continues to be a hot topic of debate and study. One
question of interest is whether mtDNA mutations are a cause or consequence of aging. The
mitochondrial theory of aging supports the idea that mtDNA mutations are a result of the aging
process (Sohal and Weindruch, 1996). The alternative theory is the concept of clonal expansion
of mtDNA mutations that accumulate over the lifetime of an individual, leading to dysfunction
of the respiratory complex, followed by the observed aging phenotypes and age-related diseases
(Elson et al., 2001). This is of particular interest in post-mitotic cells and tissues, such as skeletal
muscle, myocardium, brain and oocytes. As previously stated, the mitochondrial bottleneck
theory states that limited number of mtDNAs are selected for replication. If the oocyte selected
for ovulation contains a small percentage of founder mtDNA with rearrangements that escaped
the bottleneck, then the resulting oocyte would contain an abnormally high percentage of
rearranged mtDNAs and thus a high percentage on non-functional mitochondria. It is well
established that mtDNA mutations must meet a critical threshold in order to result in age-related
phenotypes. However, it is currently unknown exactly how long this process takes, i.e., do
mtDNA mutations occur early in life and through years of replication clonally expand as the
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individual ages? Thus, it would follow that the mtDNA mutations are a cause of aging, instead
of a result. Most likely, some combination of both of these processes is the culprit of aging and
age related diseases.
Genome and Replication
Mammalian mtDNA is a double-stranded, closed-circular molecule of approximately
16.6 kb in the human and non-human primate (Figure P1).

Figure P1. Human mtDNA Genome
The two strands of mtDNA are classified as either the heavy (H) or light (L) strand. The
H strand is thusly named because it is guanine rich and it encodes most of the regulatory
information: 2 rRNAs, 14 tRNAs and mRNAs for 12 of 13 polypeptides encoded by mtDNA.
The L strand only encodes 8 tRNAs and 1 mRNA. There are only two non-coding regions of
mtDNA. The primary region is a triple stranded structure called the displacement loop (DLoop), approximately 1kb long, within which is the site of heavy strand replication (OH). The DLoop is triple stranded due to the frequent termination of the nascent H strand approximately
700bp downstream of OH, which remains annealed to the parental L strand, thus leaving three
strands present in the D-Loop. Also located within the D-Loop are the sites of the promoters for
both H and L strand transcription, as well as multiple binding sites for mitochondrial
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transcription factor A (Tfam). The second non-coding region is approximately two thirds of the
mtDNA length from the OH, is only ~30bp in length, and is the origin of replication for the light
strand (OL).
Mitochondria are unique organelles in that they require the contribution of both the
nuclear and mitochondrial genome. The bulk of mitochondrial proteins are encoded in the
nucleus, synthesized in the cytoplasm, then imported and processed inside the mitochondrion.
The mitochondrial genome contributes a small subset of proteins necessary for the OXPHOS
pathway and is quite different from the nuclear genome for several reasons: 1) Cells contain
hundreds of mitochondria and each mitochondrion contains 2-10 identical copies of mtDNA,
while each cell only contains one copy of the nuclear genome, 2) The mitochondrial genome is
considered maternally inherited, with the paternal contribution being eliminated by an ubiquitindependent mechanism during fertilization (Sutovsky et al., 1999, 2000). However, this process
of ubiquination has been questioned in the human as a paternal mitochondrial contribution has
been detected in children in specific cases, thus leading to mitochondrial heteroplasmy (St John
and Schatten, 2004). However, for the scope of this report, we will consider mtDNA to be only
maternally inherited. 3) The mtDNA genome has considerably less efficient repair mechanisms
than that of nuclear DNA. There is only one known mtDNA polymerase, gamma or PolG; and
the only repair function is the 3’-5’ exonuclease linked to the catalytic subunit of PolG. In all
vertebrates, PolG is encoded in the nucleus and contains two subunits: a large catalytic subunit
that harbors the 3’-5’ exonuclease and 5’deoxyribose phosphate (dRP) lyase activities, and a
smaller accessory subunit which increases both the catalytic activity and processivity of the
catalytic subunit.

PolG has conserved polymerase and exonuclease domains and the

combination of the two domains is responsible for the high-fidelity of mtDNA replication with
an average error rate in humans of approximately 1 error/500,000 bp in vitro (Lee and Johnson,
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2006; Longley et al., 2005). Diseases such as progressive external ophthalmoplegia (PEO),
Kearns Sayer syndrome (KSS), Alpers syndrome and ataxia, as well as symptoms of premature
menopause, progressive muscle weakness, parkinsonism, and male infertility are coupled with
mutations in human PolG (Luoma et al., 2004; Mancuso et al., 2004; Naviaux and Nguyen,
2004; Van Goethem et al., 2001; Zeviani et al., 1988; Zeviani et al., 1989). Reported mutations
are primarily recessive and generally associated with other PolG mutations or with mutations in
other genes that encode proteins involved in mtDNA replication, i.e. Twinkle.
Twinkle (PEO1) is an mtDNA helicase important for mtDNA replication and to date
appears to be the rate limiting step in mtDNA replication initiation (Korhonen et al., 2003;
Spelbrink et al., 2001; Tyynismaa et al., 2005). Mutations in Twinkle are associated with
multiple mtDNA deletions and inhibition of Twinkle expression in cultured cells results in rapid
mtDNA depletion, suggesting that it is required for mtDNA maintenance.

In contrast,

overexpression of Twinkle in transgenic mice results in increased mtDNA copy number
(Tyynismaa et al., 2004).

Furthermore, Twinkle helicase activity is stimulated by the

mitochondrial single stranded DNA-binding protein (SSBP1), which acts as a stabilizer of
mitochondrial chromosome and nucleoid structure (Korhonen et al., 2003). Together with PolG,
these proteins form a minimal replisome (Figure P1) capable of synthesizing 16kb lengths of
DNA in cell–free systems (Kaguni, 2004; Korhonen et al., 2003), since PolG alone is unable to
support DNA synthesis. Twinkle also co-localizes with Tfam and SSBP1.
Mitochondrial Transcription
Transcription of mtDNA takes place following interaction between the nuclear-encoded
regulatory proteins and regions within the mitochondrial D-Loop.

Transcription requires

mitochondrial RNA polymerase (Polmt) (Tiranti et al., 1997), Tfam (Fisher and Clayton, 1985,
1988), and at least one of the transcription factors Tfb1m or Tfb2m (Falkenberg et al., 2002).
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Several studies suggest that transcription is initiated bi-directionally at two promoters, HSP and
LSP for heavy and light strands, respectively, within the D-Loop regulatory region (Clayton,
2000; Shadel and Clayton, 1997). Light strand transcription commences from the LSP to the
second conserved sequence block within the D-Loop region, generating a complementary RNA
sequence (Xu and Clayton, 1995). Binding of PolG to the resulting sequence enables replication
of the heavy strand to initiate within the D-Loop. Both promoters share a critical upstream
enhancer that serves as the recognition site for Tfam, an HMG-box protein that stimulates
transcription through specific binding to upstream enhancers. Tfam can bend and unwind DNA
and is linked to its ability to stimulate transcription upon binding DNA (Fisher et al., 1992).
Both Tfb1m and Tfb2m proteins work together with Tfam and Polmt to direct initiation from
HSP and LSP. Knockdown of the Tfb2m isoform results in reduced mtDNA transcription and
copy number, while knockdown of Tfb1m appears to have no effect on mtDNA transcription or
replication (Matsushima et al., 2005). Termination of mitochondrial transcription is associated
with the specific initiation site for H-strand transcription, via the mitochondrial transcription
termination factor (mTERF) (Martinez-Azorin, 2005).
Mitochondrial Dynamics
In mammalian cells, the size and shape of mitochondria varies widely, ranging from long,
interconnected tubules to individual, small spheres. In some cell types, the mitochondrial
population consists mostly of tubules, which constantly migrate back and forth along
microtubule tracks (Chen and Chan, 2004). In other cell types, the actin cytoskeleton is used for
transport (Hollenbeck and Saxton, 2005).

During migration along these tracks, individual

mitochondria can encounter each other and undergo fusion, resulting in mixing of both lipid
membranes and intra-mitochondrial content (Detmer and Chan, 2007). Conversely, individual
mitochondria can divide by fission to yield two or more smaller mitochondria. In addition to
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changes occurring during migration, the internal structure of mitochondria can change in
response to their physiological state. The length, shape, size and number of mitochondria are
maintained by fusion and fission. At steady state, dynamic events are balanced to maintain the
overall morphology of the mitochondria. When this balance is disturbed, remarkable transitions
in mitochondrial shape can occur.
Genetic studies have shown that cells with a high fusion:fission ratio have few, long and
highly interconnected mitochondria (Bleazard et al., 1999; Chen et al., 2003; Sesaki and Jensen,
1999; Smirnova et al., 2001). Conversely, cells with a high fission:fusion ratio have higher
numbers of smaller, spherical mitochondria referred to as fragmented mitochondria (Detmer and
Chan, 2007). These fragmented mitochondria lead to apoptosis by regulating the release of
cytochrome C and caspase into the inner membrane space (Detmer and Chan, 2007; Youle and
Karbowski, 2005). Mitochondria proliferate on their own during the cell cycle in a manner
similar to bacterial division.

The dynamics of mitochondrial division are essential for

mitochondrial function. A fundamental role of mitochondrial division in multiple cell types is
the maintenance of appropriate distribution of mitochondria. Mitochondrial division can lead to
a distorted mitochondrial network that allows areas of the cell to be devoid of mitochondria,
resulting in altered cellular division.

It has been shown in mammals that disruption of

mitochondrial division can result in loss of membrane potential, increased ROS and oxidized
proteins, as well as mtDNA loss (Lackner and Nunnari, 2008). The ability to identify areas of
high and low mitochondrial density within cells may lead to the ability to identify normal
mitochondrial distribution patterns.
It has been shown in pronuclear oocytes and early cleavage stage embryos in multiple
species, including hamster (Barnett et al., 1996) and mouse (Van Blerkom, 1991), that
mitochondria have a distinct perinuclear translocation and that perturbations from these patterns
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result in embryonic lethality. In the human, mitochondrial localization patterns are significantly
different between individual oocytes and between and among cohorts. However, pronuclear
oocytes that showed a pronounced asymmetrical mitochondrial distribution during syngamy
continued to show an asymmetrical distribution after the first cell division, and between
blastomeres throughout embryo development. When analyzed individually, the blastomeres
containing less mitochondria also had lower ATP content compared to blastomeres with higher
mitochondrial content (Van Blerkom et al., 2000). It is well established that during the early
stages of development, embryo competence depends upon ATP produced by mitochondria
inherited from the mother (Gardner and Lane, 1998).

During the early stages of embryo

development, energy is produced by OXPHOS via amino acids, lactate and pyruvate, with the
glucose pathway proving to be harmful at this stage; indicating that a threshold of mitochondrial
activity is necessary to support energetic demands (Tarazona et al., 2006). Once embryonic
genome activation begins, the metabolic activity of the embryo increases as it becomes capable
of using alternative pathways such as anaerobic glycolysis, allowing mitochondrial activity to
decrease. It has been shown that embryos that are developmentally incompetent have lower
mitochondrial activity and inhibited cleavage. While the lack of mitochondrial organization has
been correlated to poor implantation in the human (Scott and Smith, 1998), the exact influence of
mitochondrial distribution on embryo competence remains to be determined.
The molecular analysis of mitochondrial dynamics began in 1997 with the identification
of the Drosophila mitofusin gene Fzo (Hales and Fuller, 1997). Fzo is a mitochondrial outer
membrane GTPase required for mitochondrial fusion during spermatogenesis. The core genes
mediating mammalian mitochondrial fusion are Mfn1, Mfn2 and Opa1. Mfn1 and Mfn2, the
mammalian homologues to Fzo, are large GTPases with similar homology and topologies that
reside on the outer mitochondrial membrane (Chen and Chan, 2004). Opa1 is an inter membrane
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space protein and is also essential for fusion (Detmer and Chan, 2007). The exact relationship
between these proteins remains unclear; however cells lacking any of the three proteins have
been shown to have inhibited respiratory capacity. Additionally, the contact between the inner
and outer membranes, where these proteins reside, is essential to mitochondrial fusion (Detmer
and Chan, 2007). During apoptosis structural changes in mitochondria, such as fragmentation,
occur, leading to increased fission activity.

Concurrently, mitochondrial outer membrane

permeabilization (MOMP) causes the release of contents of the intermembrane space, including
cytochrome c, which is sequestered in the cristae, into the cytoplasm. Once in the cytosol,
cytochrome c activates caspases that propagate and execute apoptosis. Inhibition of fission
blocks mitochondrial fragmentation, reduces cytochrome c release and can reduce or delay
apoptosis (Detmer and Chan, 2007). The core genes mediating mitochondrial fission are Drp1,
Fis1 and MTP18. Drp1 is a large dynamin-related GTPase located primarily in the cell cytosol.
A portion of Drp1 moves to the mitochondrial tubule where it interacts with Fis1 (Parone et al.,
2006). Fis1 is a transmembrane protein anchored to the mitochondrial outer membrane. Both
Drp1 and Fis1 have been implicated in mitochondrial outer membrane permeability and mediate
downstream apoptosis (Chen and Chan, 2004). Inhibition of Drp1 has been shown to delay
mitochondrial division and partially inhibit apoptosis. MTP18 is a mitochondrial protein that
contributes to the balance of mitochondrial fission and fusion. Changes in the expression levels
of MTP18 interfere with the balance of mitochondrial fission and fusion; whereas loss results in
increased mitochondrial fusion and an increase results in increased number of fragmented
mitochondria (Tondera et al., 2005).

19

Figure P2: Proposed interaction of genes involved in the control of mitochondrial dynamics,
movement and mtDNA replication.
Mitochondria, which are among the most abundant and mobile membrane-bound
organelles, move along both microtubules and actin, using microtubule-based molecular motors
for long distance movements (Morris and Hollenbeck, 1995) (Figure P2).

Distribution of

mitochondria varies in response to multiple regulatory cues such as energy requirements, growth
factors and mitochondrial membrane potential (Chada and Hollenbeck, 2004; Miller and Sheetz,
2004; Morris and Hollenbeck, 1993). Conventional kinesin moves mitochondria to the plus ends
of microtubules, while dynein moves them toward the minus ends (Pilling et al., 2006; Tanaka et
al., 1998). Two research groups identified two different components important for transport;
Milton (Stowers et al., 2002), involved with kinesin heavy chains, and Miro (Guo et al., 2005), a
GTPase which is an integral outer mitochondrial membrane protein. Mutation in either of these
genes appears to abolish anterograde mitochondrial transport. Glater et al. (Glater et al., 2006)
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showed that kinesin, Milton, and Miro work together in anterograde transport and that Milton
attaches kinesin to mitochondria through Miro. Pink1, a putative serine–threonine kinase that
localizes to the outer mitochondrial membrane, has been shown to have a role in cellular
protection against oxidative stress and to affect mitochondrial dynamics. Recent ndings have
shown that Pink1 interacts with the Miro/Milton complex and that overexpression of either Miro
or Milton can suppress mitochondrial fragmentation induced after Pink1 silencing (Weihofen et
al., 2009). Pink1 and Parkin, a gene associated with Parkinson’s disease, are linked in a common
pathway that is involved in the protection of mitochondrial integrity and function (Pridgeon et
al., 2007). Our lab has recently found that monkey oocytes have an abundance of Miro1 and 2,
Milton, Pink1, Parkin, Mfn1, Mfn2 and Drp1 (unpublished data). Therefore we speculate that
mitochondrial trafficking is important for fusion and fission mechanisms and may impact oocyte
and embryo quality.
Oocyte and Embryo Quality
In order to adequately assess oocyte and embryonic potential, both qualitative and
quantitative biology of the structure must be considered. The morphological appearance or
qualitative assessment of oocytes and embryos coupled with growth rates are heavily relied upon
in ART programs. Basically, the oocyte or embryo that best fits the established standards of
what it “should” look like is considered the most likely to develop normally. While it is
generally accepted what a “bad” embryo or oocyte looks like, it is entirely subjective as to what a
“good” embryo looks like and is not a definitive indication of embryonic viability. While there
are likely many avenues to explore when developing better methods for evaluating oocyte and
embryo quality, two approaches we are particularly interested in are the proper timing of the
resumption of meiosis and mitochondrial distribution and dynamics.
In order for proper fertilization to occur, the GV-stage oocyte, which is arrested at the
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diplotene stage of metaphase I, must first resume meiosis and arrest again a MII, with the
extrusion of the first polar body. The use of standard ART protocols in human infertility
treatment can result in the failure of meiotic resumption in 15 – 27% of oocytes within the
standard 36 h after the administration of human chorionic gonadotrophin (hCG) (de Vos et al.,
1999; Junca et al., 1995). Immature oocytes (GV or MI) may be collected at oocyte retrieval
along with mature MII oocytes. Typically, oocytes are collected 32-34 hours post hCG and
cultured for approximately 4 hours, after which some immature oocytes will extrude a polar
body and may subsequently be used for IVF. Multiple studies reveal that immature human MI
and GV oocytes maturing overnight or even within a few hours have lower fertilization rates in
comparison to oocytes that were mature at retrieval (Balakier et al., 2004; de Vos et al., 1999;
DeScisciolo et al., 2000; Huang et al., 1999; Nogueira et al., 2000; Shu et al., 2007; Strassburger
et al., 2004). Embryos originating from immature GV and MI oocytes incubated overnight to
attain maturity were qualitatively inferior when compared to those resulting from oocytes that
were mature at the time of retrieval (DeScisciolo et al., 2000; Nogueira et al., 2000). It is fairly
common for immature MI oocytes from human IVF cycles to be fertilized and develop into
‘morphologically normal’ embryos (de Vos et al., 1999; Huang et al., 1999; Junca et al., 1995;
Strassburger et al., 2004), however these embryos generally lead to reduced pregnancy and live
birth rates (de Vos et al., 1999; Vanhoutte et al., 2005).
Mitochondria as Indicators of Oocyte and Embryo Quality
When considering the quantitative aspects of mitochondria in oocyte and embryo
development, it is well established that both oocytes and embryos require a certain threshold of
OXPHOS capacity to function and develop normally.

During mitosis, mitochondria are

distributed randomly among the blastomeres in the embryo. If a particular blastomere does not
acquire a sufficient number of ATP producing mitochondria, it may fragment, thus affecting the
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qualitative assessment of the embryo (Cummins, 2004).
Because mitochondria play such a significant role in oocyte and embryonic development,
oocytes and embryos are also subject to the same oxidative damage as any slow or non-dividing
cell or tissue. The accumulation of mtDNA mutations due to ROS damage or the aging process
affects oocytes and embryos in the same manner that they affect skeletal muscle or neuronal
tissue. The time at which these mutations accumulate and how they are passed from one
generation to the next are areas of extensive research. Slow and non-dividing cells such as
neurons, skeletal muscle and oocytes appear to harbor a higher percentage of mitochondrial
mutations than rapidly dividing cells, possibly due to the proximity of mtDNA to highly
mutagenic ROS generated in the mitochondria (Brenner et al., 1998). Understanding why a high
proportion of seemingly normal oocytes give rise to developmentally incompetent embryos
following IVF is increasingly important in infertility research. Oocytes arrested at the GV stage
are relatively anaerobic and subsist in a metabolically quiet environment, which may protect the
genome from DNA damage and mutation. Their OXPHOS needs are likely quite minimal, as
long as there is sufficient available glucose, anaerobic ATP production may satisfy all energy
needs. The presence of mtDNA deletions and point mutations in oocytes may have no effect
prior to a replication event. However, once ATP requirements increase, metabolic deficiencies
or replication disorders in some infertile women and in women of increased reproductive age
may cause qualitatively normal oocytes to develop abnormally. In other words, mitochondrial
dysfunctions or genetic anomalies present in the oocyte may be critical determinants of
developmental competence of the embryo (Barritt et al., 2000b; May-Panloup et al., 2005; Van
Blerkom, 2004). Human IVF pre-implantation embryos show high frequencies of abnormal
development and early demise, with further losses seen after intra-uterine transfer, when
measured by outcome per embryo.
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While a direct relationship between mitochondrial mutations in oocytes and embryos and
reproductive success has not been demonstrated, it is generally assumed that there must be a
sufficient number of functional mitochondrial genomes in the embryo in order for it to develop
and implant successfully (May-Panloup et al., 2005). A high proportion of genetically abnormal
mitochondria in the oocyte could potentially reduce the number of functional mitochondria,
leading to embryonic arrest, failed implantation or mitochondrial disease.

More than 150

mtDNA rearrangements, including deletions, insertions and duplications have been identified in
various somatic cells (Wallace, 1993).

These mutations are responsible for a number of

catastrophic neuromuscular diseases such as Kearns Sayer Syndrome (KSS), chronic PEO, and
Pearson’s syndrome. MtDNA rearrangements also accumulate with age and can become more
prevalent in post-mitotic tissues (Cortopassi and Arnheim, 1990).
Among the mitochondrial mutations that have been described in humans, one that is
termed the “common deletion" or ǻmtDNA4977 entails the deletion of 4977bp (Barritt et al.,
1999; Brenner et al., 1998; Chen et al., 1995; Keefe et al., 1995). This mutation can be detected
at frequencies as high as 30% to 50% in human oocytes, although its frequency appears to be
considerably lower in embryos that are generated from the same cohorts of oocytes (Barritt et al.,
1999; Brenner et al., 1998). Other studies show that oocyte-specific mutations predominate in
the regulatory control region of the mitochondrial genome (Barritt et al., 2000a; Barritt et al.,
2000b). Age-dependent accumulations of these mutations in the mitochondrial control region
may be responsible for impaired transcription and regulated replication of mitochondria in
oocytes from older women (Barritt et al., 2000b; Michikawa et al., 1999). Support for agedependent increases in mitochondrial mutations comes from studies of skeletal muscle in rhesus
macaques that not only showed the presence of the ǻmtDNA4977 deletion, but also revealed that
multiple deletions existed in all animals older than 13 years. In some cases, the deletions were
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so extensive that large portions of the mtDNA genome were missing (Lopez et al., 2000;
Mehmet et al., 2001; Schwarze et al., 1995).

These data provide intriguing insights into

mitochondrial mutations and aging in the human female gamete that warrant further investigation
in appropriate primate models.
NHP as a Model to Study Oocyte and Embryo Quality
NHP models are particularly relevant to study due to their close resemblance to humans
in anatomy and physiology compared to more commonly employed laboratory animals, such as
rodents. The NHP, particularly the rhesus macaque, is the most appropriate animal model to
study due to evolutionary closeness and the dramatic similarities in reproductive function and
peri-implantation development. Rhesus macaque menstrual cycles are similar to those of women
in length and in steroid and protein hormone profiles. Similarities in physiology between
humans and NHP are also evident for spermatogenesis, embryo preimplantation development
and implantation. The monkey oocyte is similar in size, shape and appearance to that of the
human and does not show the pigmented appearance of some livestock species (Michaels et al.,
1982). Moreover, the developing monkey embryo displays similar requirements to those of
humans during in vitro embryo culture. Studies involving ovarian, hormonal, and pituitary
functions of rhesus macaques have consistently shown biological changes mirroring those known
to occur in women. Rhesus monkey ART has been quite successful and provides an excellent
animal model for human IVF. Furthermore, because of NIH federal restrictions, studies utilizing
human oocytes and embryos from infertility clinics remain prohibited. Therefore, the NHP has
been established as a clinical translational model for understanding mechanisms of oocyte
maturation, reproductive aging, pre- and peri-implantation development, and derivation of ESCs
for differentiation and therapeutic and regenerative medicine (Steuerwald et al., 2000). We
postulate that mitochondrial dysfunction in oocytes and embryos may occur due to the
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breakdown of mtDNA repair machinery which alters processes related to mtDNA mutations,
nucleoid stability and mitochondrial dynamics. The oocyte is an ideal model to study since it is
associated with dysfunctions such as a decrease in mitochondrial membrane potential, increase
of mtDNA damages, chromosomal aneuploidies, the incidence of apoptosis, and changes in gene
expression. It has been suggested that these mitochondrial changes may arise from ROS that are
closely associated with the oxidative energy production and calcium.

Thus understanding

aspects of mitochondrial dynamics, such as fusion, fission and transport in the oocyte may lead
to a better understanding of important biological mechanisms and thus leading to new
therapeutics.
The central goals of this study were to evaluate mitochondria in NHP oocytes and
embryos, to determine how mtDNA mutations and mitochondrial function affect oocyte and
embryo quality and to further establish the rhesus macaque as an excellent comparative model to
study preimplantation development in the human. The major topics addressed in this dissertation
were:
•

determine if there is a large mitochondrial mutation present in rhesus macaque oocytes
and embryos similar to the common deletion (mtDNA4977) seen in humans

•

determine if mature oocytes and IVF produced embryos from gonadotrophin stimulated
rhesus macaques harbor a higher proportion of specific mtDNA mutations than immature
oocytes from non-stimulated monkeys

•

determine if the rhesus common mutation is present in in vitro and in in vivo derived
embryonic stem cell lines, as well as adult stem cell lines

•

determine if polymorphisms in the mtDNA control region as well as polymorphisms in
the mtDNA repair mechanism, PolG, are associated with aging

•

determine if failure of oocytes to reach meiotic maturity is due to specific polymorphisms
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in the mtDNA control region
•

determine if mtDNA control region sequence differences exist between embryos

•

identify methods to improve gonadotrophin stimulation protocols and IVF efficiency at
the Caribbean Primate Research Center

•

determine if, during syngamy, expression of genes involved in mitochondrial dynamics,
transport and replication are influenced by meiotic stage of gonadotrophin stimulated
oocytes at the time of collection

•

determine if expression of genes involved in mitochondrial dynamics, transport and
replication are influenced by mitochondrial distribution during syngamy

•

determine expression profiles of genes involved in mitochondrial dynamics, transport and
replication during syngamy and early embryo development
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CHAPTER 2
SPECIFIC AIM 1
Introduction
Specific Aim 1.1: To determine if the rhesus macaque can be utilized as a clinically
translational model for mitochondrial mutations identified in human IVF.
Specific Aim 1.2: To determine if the rate of mitochondrial mutations in rhesus macaque
oocytes and IVF produced embryos is increased due to gonadotrophin stimulation.
Understanding why a high proportion of seemingly normal oocytes give rise to
developmentally incompetent embryos following IVF is a high priority for human infertility
clinics. Human IVF preimplantation embryos show high frequencies of abnormal development
and early demise, with further losses seen after intra-uterine transfer, when measured by outcome
per embryo. One hypothesis is that mitochondrial dysfunctions or genetic anomalies in the
oocyte may be critical determinants of developmental competence of the embryo (Barritt et al.,
2000a; May-Panloup et al., 2005; Van Blerkom, 2004). More than 150 mtDNA rearrangements,
including deletions, insertions and duplications have been identified in various somatic cells
(Wallace, 1993). These mutations are responsible for a number of catastrophic neuromuscular
diseases such as Kearns-Sayre syndrome (KSS), chronic progressive external ophthalmoplegia
(CPEO) and Pearson’s syndrome. Mitochondrial DNA rearrangements also accumulate with
age, and can become more prevalent in post-mitotic tissues (Cortopassi and Arnheim, 1990).
Slow and non-dividing cells such as neurons, skeletal muscle and oocytes appear to harbor a
higher percentage of mitochondrial mutations than rapidly dividing cells, possibly due to the
proximity of mtDNA to highly mutagenic ROS generated in the mitochondria (Brenner et al.,
1998). Perhaps these mutations are due to the lack of mitochondrial repair activity by the DNA
polymerase gamma (PolG) during oogenesis.
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While a direct relationship between mitochondrial mutations in oocytes and embryos and
reproductive success has not been demonstrated, it is generally assumed that there must be a
sufficient number of functional mitochondrial genomes in the embryo in order for it to develop
and implant successfully (May-Panloup et al., 2005). A high proportion of genetically abnormal
mitochondria in the oocyte could potentially reduce the number of functional mitochondria,
leading to embryonic arrest, failed implantation or mitochondrial disease.
Among the mitochondrial mutations that have been described in humans, one that is
termed the “common deletion" or ǻmtDNA4977 entails the deletion of 4977bp (Barritt et al.,
1999; Brenner et al., 1998; Chen et al., 1995; Keefe et al., 1995). This mutation can be detected
at frequencies as high as 30% to 50% in human oocytes, although its frequency appears to be
considerably lower in embryos that are generated from the same cohorts of oocytes (Barritt et al.,
1999; Brenner et al., 1998). This is intriguing, considering that surplus embryos available for
analysis in clinical IVF programs are generally classified as developmentally defective. In
addition to the ǻmtDNA4977 deletion, a further 23 novel mtDNA rearrangements have been
described in human oocytes and embryos (Barritt et al., 1999). Using a nested PCR strategy,
mtDNA rearrangements can be detected in 51% and 32% of human oocytes and embryos,
respectively. Multiple rearrangements were detected in 31% of oocytes and 14% of embryos.
Other studies show that oocyte-specific mutations predominate in the regulatory control region
of the mitochondrial genome (Barritt et al., 2000a; Barritt et al., 2000b).

Age-dependent

accumulations of these mutations in the mitochondrial control region may be responsible for
impaired transcription and regulated replication of mitochondria in oocytes from older women
(Barritt et al., 2000a; Michikawa et al., 1999). These data provide intriguing insights into
mitochondrial mutations and aging in the human female gamete that warrant further investigation
in appropriate primate models.

Support for an age-dependent increase in mitochondrial
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mutations comes from studies of skeletal muscle in rhesus macaques that not only showed the
presence of the ǻmtDNA4977 deletion, but also revealed that multiple deletions existed in all
animals older than 13 years. In some cases, the deletions were so extensive that large portions of
the mitochondrial genome were missing (Lopez et al., 2000; Mehmet et al., 2001; Schwarze et
al., 1995). The specific aims of this study, therefore, were to determine if mature NHP oocytes
and embryos generated by IVF have a higher frequency of the rhesus macaque ǻmtDNA4977
deletion (common deletion) than immature NHP oocytes.
Material and Methods
Ovarian Stimulation, Oocyte Recovery and In Vitro Fertilization
All animals were used with approval of the Tulane University’s Institutional Animal Care
and Use Committee. Ovarian stimulation and oocyte recovery were performed as previously
described by Schramm (Schramm et al., 2002). Briefly, females were observed for signs of
menstrual activity and were subjected to follicular stimulation via intramuscular injections of
recombinant human follicle stimulating hormone (FSH) over an eight day period. On the 9th day
of FSH injections, the animal was injected with recombinant human chorionic gonadotropin
(hCG). Cumulus-oocyte complexes were collected from anesthetized animals by laparoscopic
follicular aspiration (27-30 hours post hCG) and placed in HEPES buffered TALP (modified
Tyrodes’ solution with albumin, lactate and pyruvate) medium (Bavister et al., 1983b) at 37°C.
The cohort of oocytes was randomly split into two groups that were either immediately used for
mtDNA analysis or subjected to IVF. Oocytes to be fertilized were transferred to equilibrated
CMRL medium (Gibco Cell Culture, Invitrogen, Carlsbad, CA, USA) in oil with 5% CO2 at
37°C.
Rhesus semen was collected by penile electroejaculation as described by Lanzendorf
(Lanzendorf et al., 1990). Following liquefaction for 15 min at room temperature, the sample
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was washed twice in TALP-HEPES by centrifugation for 7min. at 350g. Sperm count and
motility analyses were performed and the spermatozoa were resuspended in TALP-HEPES; then
the sperm suspension was stored at room temperature.

Approximately 1 hour before

insemination, spermatozoa were exposed to 1 mM dibutyryl cyclic adenosine 3’,5’monophosphate (dbcAMP) and 1mM caffeine for sperm activation (Bavister et al., 1983b).
For IVF, oocytes were inseminated with 5x104 activated spermatozoa and cultured in 50
µl drops of CMRL at 37°C in 5% CO2. Oocytes were examined 10-16 hours post insemination
for the presence of pronuclei. Oocytes with pronuclei were cultured for 48 hr (to approximately
the 8-cell stage) in HECM-9 (Bavister et al., 1983b).
DNA Purification
Embryos and oocytes (denuded of cumulus cells using 10mg/ml hyaluronidase dissolved
in TL-HEPES) were stripped of their zonae pellucidae with acid Tyrode’s solution (SigmaAldrich, St. Louis, MO, USA). They were individually placed into 0.2 ml PCR tubes with 3 ȝl
of 0.1% polyvinyl alcohol (PVA) in phosphate buffered saline (PBS). Samples were stored at 20°C until use. Prior to PCR, 3 ȝl of a mixture of 4x10-4 M sodium dodecyl sulfate (SDS;
Sigma-Aldrich) and 125 ȝg/ml proteinase K (Roche Diagnostics Corp, Indianapolis, IN, USA)
were added to each tube for cell lysis. The tubes were incubated at 37°C for 1 hr, and then
heated to 95°C for 15 min to inactivate proteinase K.
The gene-specific oligonucleotide primers used in this study were synthesized by Sigma
Genosys (The Woodlands, TX, USA). To amplify the internal control mtDNA region and the
rhesus common deletion simultaneously, the DNA was divided into two 3ȝl aliquots prior to
PCR amplification. Each aliquot was amplified using a MyCycler Thermal Cycler (Bio-Rad,
Hercules, CA, USA) in a 25 ȝl reaction volume containing 1.5 mM MgCl2, 1 IU Taq
polymerase, 200 ȝM each dNTP and 0.5 ȝM gene-specific primers using the following
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amplification profile: 1 cycle of 95°C for 1 min, 30 cycles at 95°C for 25 sec, 62°C for 25 sec
and 72°C for 2 min, followed by 1 cycle at 72° C for 5 min and then a hold at 4°C. For the
nested PCR, 3ȝl of the first reaction served as a template. The nested PCR was performed using
the following profile: 1 cycle of 95°C for 1 min, 40 cycles at 95°C for 25 sec, 62°C for 25 sec
then 72°C for 2 min followed by 1 cycle at 72° C for 5 min and then a hold at 4°C. The
evaluation of PCR results was performed by agarose gel electrophoresis. Eight microliters of
nested PCR product and 2 ȝl of blue/orange loading dye were separated on 1.5% gel and stained
with ethidium bromide. The positive control for the rhesus common deletion was DNA isolated
from skeletal muscle derived from a 31 yr old male rhesus macaque, amplified under the same
conditions as the oocytes and embryos.

Figure 1: Nested PCR strategy used to detect the rhesus common deletion in the mitochondrial
DNA genome. Primers RhM15.1 (inside arrow) and RhM15.6 (outside arrow) were used as an
internal control for the presence of mtDNA. RhM15.6 (outside arrow) and RhM7.2 (inside
arrow) were used in the first PCR amplification. Primers RhM14.8 (outside) and RhM8966
(inside) were used for the nested PCR reaction to identify the 5703 bp deletion. The dashed
inside line represents the 5703 rhesus common deletion which is removed in the nested PCR
reaction if mtDNA mutations are present in the sample. Black bar indicates deleted base pairs.
PCR Detection of the Rhesus Common Deletion
To detect the rhesus common deletion, a nested PCR strategy was applied.
Oligonucleotide sequences were taken from mtDNA sequence analysis by Schwarze (Schwarze
et al., 1995). PCR primers were designed based on the corresponding sites in the human mtDNA
genome. Primer sequences and corresponding human mtDNA positions are shown in Table 1.
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Primers RhM15.1 and RhM15.6 were used for amplification of a 599bp internal control mtDNA
amplicon.

Primers RhM15.1 and RhM7.2 were used in combination with RhM14.8 and

RhM8966 using a nested PCR strategy to detect the rhesus monkey common deletion as shown
in Figure 1.
Table 1. Polymerase chain reaction (PCR) primer sequences used to detect the rhesus common
deletion in the mitochondrial genome
Name
RhM15.1
RhM15.6
RhM7.2
RhM14.8
RhM8966

mtDNA Location (nt)
15069
15643
7206
14849
8966

Sequence (5’-3’)
TCCTCCTAGAAACCTGAAACATTGG
AAGTATAGGGATGGCTGCTAGAATG
GGAATACCCCGACGCTACTCTG
AAAATTAGGCAGGCTGCAAGAAGTG
TCAGTCTACTATTCAACCAGTGGC

Statistical Analysis
A 2x2 G test was performed to determine significant differences between percentages of
non-stimulated oocytes vs. stimulated oocytes; non-stimulated oocytes vs. stimulated,
unfertilized oocytes; non-stimulated oocytes vs. IVF embryos; and all non-stimulated vs.
stimulated oocytes and embryos. The statistical formula used was
ts = (arcsine ¥P1) – (arcsine ¥P2) / ¥[820.1 (1/n1) + (1/n2)]
where P1 and P2 are the percent frequencies of the two groups being compared; n1 and n2 are
respective sample sizes; and 820.1 is a constant representing the parametric variance of a
distribution of arcsine transformations of percentages (Sokal and Rohlf, 1981). The arcsine is
the angle, in degrees, whose sine corresponds to the value given and was determined from
published tables (Rohlf and Sokal, 1981). The ts values were compared to critical values of
Student’s t distribution using a two-tailed distribution.
Results
Characterization of the Rhesus Mitochondrial Common Deletion
To validate the assay for the detection of the rhesus common deletion, the nested PCR
strategy shown in Table 1 and Figure 1 was employed. Primers RhM15.1 and RhM15.6 were
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used to amplify DNA isolated from skeletal muscle tissue of a 31 year old rhesus monkey. A
599bp internal positive mtDNA control was observed in duplicate (Figure 2; lanes 1 and 2). The
rhesus mitochondrial common deletion was amplified from the same tissue and showed a 180bp
fragment (Figure 2; lanes 3 and 4). DNA sequencing of the 180bp amplicon demonstrated that a
5703bp deletion occurred in the rhesus mitochondrial genome. Using a nested PCR reaction as
described in materials and methods, the remaining 180bp amplicon is the result of the deletion of
the 5703bp, as shown in Figure 1.

Figure 2: The rhesus common deletion was generated using DNA isolated from 31yr old rhesus
skeletal muscle. Nested PCR products were separated on 1.2% agarose gel and stained with
ethidium bromide. Lane M: 100 bp DNA Ladder. Lane 1 and 2 demonstrate the internal control
region amplified with primers RhM15.6 and RhM15.1 showing a 599 bp band. Lanes 3 and 4
show the rhesus common deletion 180 bp amplicon generated using primers RhM15.1 and
RhM7.2 followed by RhM14.8 and RhM8966.
Mitochondrial Deletions in Immature Oocytes
Using the same nested PCR strategy, a total of 127 immature oocytes excised from
necropsied ovaries (n=13 animals) were examined for the presence of the rhesus common
deletion. Only 27 of the 127 oocytes contained this deletion (21.3%). The amplification
efficiency was over 90%. The intensity of the amplified PCR product varied, indicating different
copy numbers of mtDNA among the oocytes analyzed. Skeletal muscle tissue from a 31 year old
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monkey served as a positive control and showed the same 180bp amplicon illustrated in Figure 2
Mitochondrial Deletions in NHP Oocytes and Embryos
Using the same PCR amplification strategy, a total of 22 metaphase II (MII) oocytes (n=4
animals), 17 oocytes that failed to fertilize (n=3 animals) and 31 day three embryos (n=6
animals) were tested for presence of the common deletion. Surprisingly, 77.3% of the stimulated
MII oocytes, 70.6% of failed fertilized oocytes and 67.7% of the embryos harbored this mutation
(Table 2). Figure 3A (Lanes; 1-13) shows the positive mitochondrial control 599bp amplicon
from each oocyte and embryo. Figure 3B (Lanes; 1, 2, 4, 5, 6, 8, 9) shows the 180bp common
deletion. This mitochondrial deletion was not present in every oocyte and embryo in Figure 3B
(Lanes; 3, 7, 6, 11, 12, 13). There was a substantial difference in the band intensity of the
common deletion in oocytes and embryos. In addition, faint PCR products were observed with
both the positive internal mitochondrial control primers and the nested primers.

Table 2. Detection of the mtDNA rhesus common deletion in rhesus oocytes and embryos by
nested PCR.
Source
No. amplified
mtDNA
mtDNA
Detected (%)
Deleted
Non-Deleted
Necropsy oocytes
127
27
100
21.3a
Stimulated oocytes
22
17
5
77.3b
c
Stimulated UFOs
17
12
5
70.6b
IVF embryos
31
21
10
67.7b
ab

Statistically significant difference (P<0.001) by 2x2 G test and Students’ t-Test distribution. A ratio of
the number of rhesus common deletions amplified compared to the number of samples amplified indicates
the amplification frequency. cUFO = failed to fertilized oocyte.
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Figure 3: Rhesus control mtDNA and common deletion in rhesus gonadotrophin-stimulated
oocytes and day 3 embryos. Lane M: 100 bp ladder. A) Lanes 1-6 demonstrates the internal
control region amplified with primers RhM15.6 and RhM15.1 showing a 599 bp band in
stimulated oocytes. Lanes 7-13 show a 599 bp band control amplicon in IVF day 3 embryos. B)
Lanes; 1, 2, 4, 5, 6,7, 8, 9 show the rhesus common deletion or 180 bp amplicon generated in
stimulated oocytes or day 3 embryos using primers RhM15.1 and RhM7.2 followed by RhM14.8
and RhM8966.
Comparison of Non-Stimulated Oocytes and Stimulated Oocytes and Embryos that Harbor the
Mitochondrial Deletions
In the non-stimulated oocytes, 21.3% (27/127) contained the mitochondrial common
deletion compared with a frequency of 71.4% (50/70) in stimulated oocytes and embryos
(P<0.001, Tables 2 and 3).

Additionally, there was a statistically significant difference

(P<0.001) in the ratio of this mutation between non-stimulated oocytes and mature MII oocytes,
embryos and oocytes that failed to fertilize, as a group.
Discussion
Over 100 mitochondrial mutation associated diseases have been identified. In addition,
the accumulation of mtDNA deletions has been found in brain, cardiac muscle, skeletal muscle
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and liver. It was imperative that the initial mtDNA analysis be done using somatic tissue, such
as skeletal muscle, as the comparative baseline for mtDNA candidates in monkey oocytes and
embryos. Skeletal muscle biopsies collected at 3-year intervals in rhesus macaques suggest that
the increasing frequencies of mtDNA deletions are correlated with increasing age (Gokey et al.,
2004). Specific Aim 1.1 of this study was to determine if the rhesus macaque can be utilized as a
clinically translational model for mitochondrial mutations identified in human IVF. In order to
do this, a nested PCR strategy was applied using skeletal muscle from a 31 year old monkey.
Analysis by PCR generated a 180bp PCR mtDNA fragment, rather than the 930bp amplicon
observed in human mtDNA (Figure 2; lanes 3 and 4). This indicates that the common deletion in
rhesus monkeys entails the loss of 5703 base pairs, which is considerably larger than the 4977bp
common deletion typically found in human KSS patients. One reason for this discrepancy might
be that the rhesus mitochondrial genome has only 80.4% nucleotide sequence homology with the
human mitochondrial genome and may contain altered sites of preferential replication errors
(Gokey et al., 2004). Using the same nested PCR strategy shown in Figure 1, 127 immature
oocytes and 70 stimulated oocytes and IVF embryos were evaluated for the rhesus mitochondria
common deletion (Tables 2 and 3). Through these data, we conclude that the rhesus macaque is,
in fact, an excellent model to study mtDNA mutations found in human oocytes and IVF
produced embryos.
The second specific aim of this study was to determine if the rate of mitochondrial
mutations in rhesus macaque oocytes and IVF produced embryos is increased due to
gonadotrophin stimulation.

We found that the frequency of common mtDNA mutation in

immature germinal vesicle (GV) oocytes excised from necropsied ovaries was low (21.3%) when
compared with gonadotrophin-stimulated MII oocytes and embryos (71.4%).

The precise

mechanisms responsible for this increase are unknown. It has been suggested that there is a
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massive amplification of the mitochondrial genome during the process of oogenesis, presumably
to support the initial period of embryonic development. The average mtDNA copy number of
the human MII oocyte has been estimated to be 795,000 (+/- 243,000) (Barritt et al., 2002).
However, it is not known whether the number of mtDNA molecules remains stable during
primate preimplantation development.

It has recently been suggested that mitochondrial

replication occurs during a very short period of time from the 1-to 2-cell stage in the mouse
embryo prior to fertilization (McConnell and Petrie, 2004).

It is therefore unclear when

mitochondrial transcription and replication actually begin in primate oocytes and embryos. It has
been shown that preimplantation mouse embryos are dependent upon the energy produced from
mitochondria derived solely from the oocytes, and that mitochondrial replication does not occur
until the blastocyst stage (Piko and Taylor, 1987; Smith and Alcivar, 1993). In fact, the mtDNA
copy numbers remain remarkably stable throughout preimplantation development. Moreover, it
has been reported that there is a high variability of mtDNA copy numbers among individual
mouse blastocysts, suggesting that some embryos may be able to initiate mtDNA replication
before implantation (Thundathil et al., 2005). The increase in the mtDNA common deletion in
stimulated rhesus MII oocytes and embryos shown here implies that mitochondrial replication
may occur during either exogenous gonadotrophin stimulation, and/or during oocyte maturation
in the rhesus macaque.
The mechanisms that regulate mitochondrial replication and function during oogenesis
and preimplantation development are largely unknown but are likely dependent on nuclearencoded factors, such as mitochondrial transcription factor (Tfam), nuclear respiratory factor 1
(Nrf1), mitochondrial RNA polymerase (Polmt) and TFB1M and TFB2M. It is unknown how
mitochondrial replication processes might generate mitochondrial deletions and point mutations
in aging tissues or non-dividing cells such as oocytes. One theory is that ROS in the vicinity of
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the mtDNA can cause both single-stranded and double-stranded breaks before Tfam binds to and
stabilizes the mtDNA (Trifunovic et al., 2004).
It has long been assumed that all of the mitochondria in the mature MII oocyte arise from
the clonal expansion of an extremely small number of mitochondria during oogenesis, but it has
never been determined precisely when these events take place (Van Blerkom, 2004). Perhaps
during the clonal expansion of these mitochondria, the rapidity of the replication process causes
mtDNA defects. Recent data show that oocyte ATP content increases significantly during
porcine IVM similar to what has been reported in the cow (Brevini et al., 2005; Stojkovic et al.,
2001). These data suggest that mitochondrial replication may also occur during porcine and
bovine IVM.
One explanation for the high frequency of mtDNA defects in oocytes from
gonadotrophin-stimulated humans and monkeys (Barritt et al., 1999; Brenner et al., 1998; Chen
et al., 1995; Keefe et al., 1995) and present study) is that administration of high doses of
exogenous FSH recruits many more follicles than in a natural cycle, so that numerous defective
oocytes that were destined for atresia are aspirated along with normal oocytes. As a corollary,
the proportion of oocytes with mtDNA defects increases in older primates because most of the
“good” oocytes with normal mtDNA have already been recruited. If this were true, then we
would expect GV stage oocytes in unstimulated ovaries to contain a high incidence of mtDNA
defects, which would not change much, if at all, following gonadotrophin stimulation. However,
our data contradict this explanation. We found that the frequency of mtDNA defects (the
common deletion) was relatively low (21%) in GV oocytes from unstimulated rhesus ovaries, but
increased more than 3-fold (71%) in oocytes from follicles recruited using FSH stimulation.
This result suggests that potentially the administration of exogenous FSH causes the mtDNA
defects in oocytes. It is very unlikely that the answers can be found from human clinical data
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because of the inherent priority to obtain pregnancy rather than to examine different
gonadotrophin stimulation approaches.

Instead, the etiology of mtDNA defects in primate

oocytes must be examined using NHP, such as the rhesus monkey, in which experiments can be
designed to specifically evaluate possible effects of gonadotrophin stimulation on oocyte quality
and competence. Such experiments are in progress in our laboratory to determine if extensive
mitochondrial damage occurs during gonadotrophin stimulation and if this damage can be
repaired via the nuclear mitochondrial transcription factor polymerase gamma (PolG) during
early primate embryo development.

Figure 4: Rhesus mtDNA control and common deletion in non-stimulated germinal vesicle
(GV) oocytes. Lane M: 100 bp DNA Ladder. A) Lanes 1-12: 590 bp mtDNA amplified with
primers RhM15.1 and RhM15.6. B) Lanes 1-12 show that no PCR amplicons were generated in
the same oocytes using primers RhM15.1 and RhM7.2 followed by RhM14.8 and RhM8966.
*NOTE: Please see publication of this work for further detail (Gibson et al., 2005).

Table 3. Frequency of the mtDNA rhesus common deletion in stimulated oocytes and embryos
vs. non-stimulated oocytes.
No. amplified
mtDNA
mtDNA
Detected (%)
Deleted
Non-Deleted
Non-Stimulated
127
27
100
21.3a
Stimulated
70
50
20
71.4b
ab

Statistically significant difference (P<0.001) by 2x2 G test and Students’ t-Test distribution. A ratio of
the number of rhesus common deletions amplified compared to the number of samples amplified indicates
the amplification frequency.
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CHAPTER 3
SPECIFIC AIM 2
Introduction
Specific Aim 2: Due to the frequency of the rhesus mtDNA common mutation in
gonadotrophin stimulated, rhesus macaque MII oocytes and IVP embryos, we hypothesize
that the common mutation will also be present in embryonic stem (ES) cells derived from
IVP produced embryos.
Numerous laboratories have detected a specific mtDNA mutation, known as the common
deletion (ǻmtDNA4977), in human oocytes and IVP embryos at a frequency of 30% to 50%
(Barritt et al., 1999; Brenner et al., 1998; Chen et al., 1995; Keefe et al., 1995). These oocytes
and embryos were obtained from infertile patients. Our laboratory has recently reported that the
rhesus mitochondrial common deletion is present in fertile rhesus macaque oocytes and embryos
(Gibson et al., 2005). Oocytes from necropsied ovaries of rhesus macaques show that the
common deletion naturally occurs in 21% of GV oocytes (Gibson et al., 2005). Gonadotrophin
stimulation increases the frequency of this deletion to 77% in MII oocytes, and 68% in day three
IVP embryos (Gibson et al., 2005). These results imply that the administration of exogenous
FSH may induce mtDNA defects in oocytes, embryos and their subsequent embryonic stem cell
derivatives.
It is widely known that production of embryonic stem cell lines from the inner cell mass
(ICM) of blastocysts is difficult and incurs considerable expense. At present, 18 rhesus macaque
ES cell lines have been produced. Ten of these lines are derived from IVP blastocysts (ORMES
series) and eight from in vivo produced blastocysts (R series) flushed from the uteri of monkeys
after artificial insemination (Pau and Wolf, 2004).
Given that mtDNA mutations are present in gonadotrophin stimulated, rhesus macaque
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MII oocytes and IVP embryos, it can reasonably be inferred that such defects also persist in the
ES cells derived from them. Thus, the presence of numerous mtDNA deletions and point
mutations may actually reflect the quality of affected oocytes or primate ES cells lines. Primate
ES cell lines may harbor mutant mtDNA that may further accumulate during cell culture, and
thus have consequences for long-term viability. Therefore, one objective of this study was to
determine the prevalence of the rhesus mitochondrial common deletion in ES cells. Future
medical applications of stem cell therapies include the use of cells originating not only from
embryos but also from adult tissues (Bavister et al., 2005). Therefore, we investigated whether
the common mitochondrial mutation was present in multiple passages of an adult bone marrow
stromal stem cell line (BMSC). Finally, mtDNA from an adult adipose stromal stem cell line
(ATSC) was compared with mtDNA from ATSC-TERT, the same line immortalized through
transfection with a retroviral vector expressing telomerase.
Material and Methods
Animals
All animal procedures conformed to the requirements of the Animal Welfare Act and
protocols were approved before implementation by the Institutional Animal Care and Use
Committee (IACUC) of Tulane University and the Oregon National Primate Research Center.
DNA Extraction and PCR Analysis
To detect the rhesus common deletion, a nested PCR strategy was applied. Total cellular
DNA, from TERT-ATSCs (passages (p) 10 and 20); ATSCs (p11 and 16); BMSCs (p1, 10, 20
and 30); as well as the ES cell lines ORMES 1 (p21), 2 (p11), and 7 (p24); and R4 (p20), was
isolated using the Puregene Genomic DNA kit (Gentra Systems, Minneapolis, MN, USA). The
gene-specific oligonucleotide primers used in this study were synthesized by Sigma Genosys
(The Woodlands, TX, USA). Using a MyCycler Thermal Cycler (Bio-Rad, Hercules, CA,
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USA), each sample was amplified in a 25 µl reaction volume containing 100 ng of DNA, 1.5
mM MgCl2, 1 IU Taq polymerase, 200 µM each dNTP, and 0.5 µM gene-specific primers. For
all cell lines, the following amplification profile was used: 1 cycle of 95°C for 1 min; 30 cycles
at 95°C for 25 sec, 62°C for 25 sec and 72°C for 2 min; followed by 1 cycle at 72° C for 5 min;
and a hold at 4°C. For the nested PCR, 2µl of the first reaction served as a template. The nested
PCR was performed using the following profile: 1 cycle of 95°C for 1 min; 40 cycles at 95°C for
25 sec, 62°C for 25 sec then 72°C for 2 min; followed by 1 cycle at 72° C for 5 min; and a hold
at 4°C. Duplicate PCR reactions were performed for each sample as well as a genomic GAPDH
control for assessing PCR efficiency. The detection of all PCR results was detected by agarose
gel electrophoresis, and stained with ethidium bromide
PCR Detection of the Rhesus Common Deletion
Oligonucleotide primers used for amplification of the target sequences of mtDNA and
corresponding human mtDNA positions have been previously published (Gibson et al., 2005).
Primers for rhesus GAPDH were: GAPDH forward ACCACCATGGAGAAG GCTGG; and
GAPDH reverse TCAGTGTAGCCCAGGATGC, resulting in a 528bp DNA product after PCR
amplification.
Results
Mitochondrial Deletions in NPH Oocytes and Embryos
Using a nested PCR amplification strategy (Gibson et al., 2005), all samples amplified a
599bp amplicon as a positive mtDNA control (Figure 5A). A high proportion of rhesus macaque
MII oocytes and day 3 IVP embryos were found to harbor the rhesus mitochondrial common
deletion (Figure 5B). Over 75% of MII oocytes (n=22) and greater than 65% of IVP embryos
(n=31) harbored this mutation. Furthermore, differences in intensity of the common deletion
amplicon were detected among individual oocytes and embryos.
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Figure 5: Rhesus control mtDNA and the common deletion in rhesus gonadotrophin-stimulated
oocytes and day 3 embryos. Lane M: 100 bp ladder. Figure 1A, Lanes 1-3 demonstrate the
internal control region showing a 599 bp amplicon in stimulated oocytes. Lanes 4-6 in 1A show
a 599 bp band control amplicon in day 3 IVF embryos. Figure 1B, Lanes 1-3 show the rhesus
common deletion, a 180 bp amplicon generated in stimulated oocytes. Lanes 4-6 in 1B show the
common deletion generated in day 3 IVP embryos.
Mitochondrial Deletions in NHP ES Cell Lines
Using nested PCR, the rhesus mitochondrial common deletion was detected in all three
IVP ESC lines; ORMES 1 (p21), 2 (p11) and 7 (p24), as well as from the R4 (p20) cell line, a
rhesus ES cell line derived from an in vivo produced embryo (Figures 6 and 7, respectively).
DNA sequencing of the 180bp amplicon (Figure 6, Lanes 2, 5 and 8; Figure 7, Lanes 3 and 4)
demonstrated that it corresponded to the 5703bp deletion in the rhesus mitochondrial genome, as
previously shown (Gibson et al., 2005). This mtDNA deletion corresponds to the same deletion
found in rhesus macaque oocytes and day 3 embryos (Figure 5B). To confirm the presence of
both mitochondrial and genomic DNA, a 599bp internal control (Figure 6, Lanes 1, 4 and 7;
Figure 7, Lanes 1 and 2) and a 528bp rhesus GAPDH (Figure 6, Lanes 3, 6 and 9) were
amplified and detected.
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Figure 6: Rhesus control mtDNA, common deletion and genomic GAPDH in 3 in vitro derived
ES cell lines ORMES 1, 2, and 7. Lane M: 100 bp ladder. Lanes 1, 4, and 7 demonstrate the
internal control region showing a 599 bp amplicon in lines 1, 2 and 7, respectively. Lanes 2, 5
and 8 show the rhesus common deletion, a 180 bp amplicon generated in lines 1, 2, and 7,
respectively. Lanes 3, 6 and 9 show a genomic GAPDH control, a 528 bp amplicon generated in
lines 1, 2 and 7, respectively.

Figure 7: Rhesus control mtDNA and common deletion in the in vivo derived ES cell line R4.
Lanes M: 100 bp ladder. Lanes 1 and 2 demonstrate the internal control region showing
duplicate 599 bp amplicons. Lanes 3 and 4 show the rhesus common deletion, duplicate 180 bp
amplicons.

45

Figure 8: Rhesus control mtDNA and common deletion in the TERT-ATSC and the ATSC cell
lines. Lane M: 100 bp ladder. A) Lanes 1, 2, 5 and 6 demonstrate the internal control region
showing duplicate 599 bp amplicons from the TERT-ATSC cell line in passages 10 and 20,
respectively. Lanes 3, 4, 7 and 8 show the rhesus common deletion, a very faint duplicate 180 bp
amplicons from the TERT-ATSC cell line in passages 10 and 20, respectively. B) Lanes 1, 2 and
5 demonstrate the internal control region showing a 599 bp amplicon in duplicate (lanes 1 and 2)
and a single replicate (lane 5) from the ATSC line, passages 11 and 16, respectively. Lanes 3, 4
and 6 show the rhesus common deletion, a 180 bp amplicon in duplicate (lanes 3 and 4) and a
single replicate (lane 6) from the ATSC line, passages 11 and 16, respectively.
Detection of the Rhesus Common Deletion in Adult Stem Cells
A non-human primate adipose stromal cell line (ATSC), a telomerase induced adipose
stromal cell line (TERT-ATSC) and a bone marrow stromal cell line (BMSC) were examined for
the mtDNA common mutation. Interestingly, the TERT-transfected ATSCs grew continuously
and the rhesus common mitochondrial mutation was only faintly detected, regardless of passage
number (Figure 8A, Lanes 3, 4, 7, and 8). Non-transfected ATSC cells harbored the mtDNA
mutation at passages 11 and 16 (Figure 8B, Lanes 3, 4 and 6). The BMSC cell line showed high
levels of mitochondrial mutations in passages 3, 10 and 30 (Figure 9, Lanes 3, 4, 7, 8, 11 and
12). Both the internal control (see Figure Legends 8 and 9) and genomic GAPDH (data not
shown) were detected in all adult stem cell lines.
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Figure 9: Rhesus control mtDNA and common deletion in the BMSC cell line. Lane M: 100 bp
ladder. Lanes 1, 2, 5, 6, 9 and 10 demonstrate the internal control region showing duplicate 599
bp amplicons in passages 3 and 10 and 30, respectively. Lanes 3, 4, 7, 8, 11 and 12 show the
rhesus common deletion, duplicate 180 bp amplicons in passages 3, 10 and 30, respectively.
(*NOTE: Please see Appendix B for this publication. (Gibson et al., 2006))
Discussion
This is the first study to examine mtDNA mutations in embryonic and adult NHP stem
cell lines. In conjunction with our previous report (Gibson et al., 2005), it is now clear that
mtDNA mutations are detectable in oocytes, embryos, adult and ES cells from fertile rhesus
macaques. Over 60% of oocytes and embryos from gonadotrophin stimulated monkeys contain
mitochondrial deletions, which carried into ES cell derivatives.

It is likely that repeated

passaging of ES cell lines derived from these oocytes increases the occurrence of deletions that
may eventually render the cells metabolically impaired and, as a result, lead to developmental
incompetence (Bavister et al., 2005), although this remains to be determined.
Increasing accumulation of mtDNA mutations may be linked to aging, which has been
associated with functional competence of stem cells through changes in the activity of
telomerase, the reverse transcriptase that elongates telomeres. Transfection of the catalytic
subunit of telomerase, TERT, extends the lifespan of the transfected cell line, thus preventing
senescense (Flores et al., 2005; Kang et al., 2004). In the present study, mtDNA from an adipose
stromal cell line (ATSC) was compared with mtDNA from an immortalized (ATSC-TERT) cell
line. Interestingly, the presence of the common deletion in the ATSC-TERT cell line was
diminished compared with levels exhibited in the control (non-transfected) ATSC cell line
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(Figure 8). Similarly, adult bone marrow stromal stem cells (BMSC) showed high levels of the
rhesus mtDNA common deletion, regardless of passage (Figure 9).

Furthermore, ongoing

studies are in progress to determine whether additional deletions and point mutations are present
in representative primate stem cell lines.
Disruption of ATP production in stem cell lines may not only alter cell division rates, but
may also be related to premature apoptosis, mitochondrial disorders, the accumulation of
chromosomal abnormalities such as aneuploidies, and early differentiation or possible failure to
differentiate (Barnett et al., 1997; Chinnery et al., 2004; Eichenlaub-Ritter et al., 2004;
McConnell and Petrie, 2004; Van Blerkom et al., 2000; Van Blerkom et al., 1995a). Preliminary
results from our laboratory also indicate that mitochondrial properties, such as ATP production,
may change in adult stem cell lines, supporting the results reported in the present study that adult
stem cell lines may harbor defects in mitochondrial integrity and function (Lonergan,
unpublished results). It has also been proposed that functional mitochondrial defects could also
result from the asymmetric distribution of mitochondria during cell division, leading to
disproportionate mitochondrial inheritance and a subsequent diminished ATP-generating
capacity (Van Blerkom et al., 2000; Van Blerkom et al., 1995b).
The successful use of stem cell lines for therapeutic cell replacement or for drug
development and testing will require that cells exhibit physiological and molecular stability over
extended periods of culture. If stem cell lines accumulate mtDNA mutations with increased time
in culture, the functional competence of these lines may be compromised. Our results, as well as
others (Maitra et al., 2005), indicate that the characterization of mtDNA mutations in both nonhuman primate and human cell lines has important implications for establishing the normality of
cell lines prior to use in future studies. A strong argument has previously been presented for the
detailed characterization of NHP stem cell lines (Bavister et al., 2005).
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At this time, there are no established molecular and cellular markers to ascertain which
cell lines are defective or functionally competent.

The key question is what functional

characteristics, important for normal differentiation of these cell lines, should be used to select
the most normal lines for further in-depth studies, particularly prior to organ and tissue
derivation for use in human ES cell technologies? It is of concern that mtDNA mutations are
found in a wide spectrum of cancers and aging tissues (Wallace, 2005). The possibility remains
real that the use of aberrantly developing stem cells for therapeutic cell replacement could lead to
the development of cancer. NHP ES cells, created from presumptively normal blastocysts, are
derived from oocytes of young, fertile monkeys. However, results of the present study show that
regardless of their origin, i.e., the in vivo derived cell line (R4) and the ES cell lines generated
from IVP embryos, all lines exhibited the common deletion (Figures 6 and 7). These results
suggest that the culture conditions under which the cell lines are maintained, or the derivation
process, may alter the occurrence of this and possibly other deletion(s). However, whether the in
vivo derived embryos exhibit the common deletion prior to generation of the stem cell line still
needs to be determined.
It is clear from the present study that the existing stem cell lines, whether generated from
in vitro or in vivo derived embryos, are not suitable for therapeutic purposes and perhaps not for
drug testing. However, their characterization will enable identification of other useful stemness
markers. It remains to be determined which lines should be selected for: (i) the development of
improved, controlled culture conditions, free from serum and mouse feeder cell layers so that ES
cells can be more reliably maintained in the undifferentiated state with karyotypic and
mitochondrial stability; (ii) elucidation of control factors, (i.e., specific alterations to the culture
milieu), growth factors, hormones, etc., to direct differentiation into derivative cell types and
tissues; and (iii) comparisons of early versus late passage cells to establish mitochondrial
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stability in prolonged culture. These studies will be considerably costly and time consuming. It
is therefore imperative to select the best ES cell lines to be used as the starting material before
committing major resources.
Mechanisms that regulate mitochondrial function during oogenesis and preimplantation
development are largely unknown but are likely dependent upon nuclear-encoded mitochondrial
transcription factor (Tfam), nuclear respiratory factor 1 (Nrf1), mitochondrial RNA polymerase
(Polmt) and mitochondrial transcription factor B1 (Tfb1m) and B2 (Tfb2m). It is currently
unknown how mitochondrial replication processes might generate mitochondrial deletions and
point mutations in aging tissues or non-dividing cells, such as oocytes. Double stranded breaks
may actually occur during the mitochondrial replication process. Furthermore, the DNA helicase
(Twinkle) or replication stalling caused by mutations in polymerase gamma (PolG) may be
partially responsible for these replication malfunctions.

DNA PolG is required for both

replication and repair of mtDNA. It has been shown that homozygous knock-in mice lacking
PolG's exonuclease function harbored deletions and mutagenesis of mtDNA with a premature
aging phenotype (Trifunovic et al., 2004).

In further studies, we plan to investigate the

molecular control of mitochondrial transcription and replication during IVP production of
preimplantation embryos (Pei and Brenner, unpublished results).
We have shown that the common deletion occurs naturally in the rhesus oocyte; that the
prevalence of this mutation is dramatically increased by gonadotrophin stimulation; and that
there is continued presence of the deletion in the day 3 IVP embryo. Due to the existence of this
same mutation in all 3 IVP derived ES cell lines examined, out of the 10 existing lines, it is
logical to extrapolate that many, if not most, NHP ES cell lines may harbor this mutation. The
rhesus common deletion was also found in two adult stromal stem cell lines. Additionally, in the
presence of a subunit of telomerase known to extend the lifespan of cells, the occurrence and/or
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replication of the mutation is limited. In both non-human primate and human stem cell lines, it is
currently unknown what mutations exist and to what extent. It is imperative that ES cell lines be
further characterized and that culture improvements be made. NHP ES cells present a valuable
alternative to human ES cells in order to address issues of safety and efficacy of transplanted
organs and tissues in NHP before any such clinical studies should be allowed in humans.
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CHAPTER 4
SPECIFIC AIM 3
Introduction
Specific Aim 3.1: To determine if increases in the presence of mutations in the mtDNA
control region, as well as the mitochondrial polymerase, PolG, are associated with aging in
the rhesus macaque.
Specific Aim 3.2: To determine if increases in the presence of mutations in the mtDNA
control region are associated with meiotic failure in oocytes.
It is thought that progressive damage to mtDNA during life contributes to the aging
process. Mitochondrial DNA rearrangements accumulate with age and become predominant in
post-mitotic, non-dividing tissues (Cortopassi and Arnheim, 1990). Similarly, in aging rhesus
macaques, high levels of mtDNA deletions can accumulate in skeletal muscle (Schwarze et al.,
1995). It has been shown that up to 50% of individuals over 65 years of age exhibit a T to G
transversion at a base pair position (414) within the mitochondrial control region that was absent
in younger individuals (Michikawa et al., 1999); as well as two other muscle-specific mutations
that accumulate with age in the critical human mitochondrial control region (Wang et al., 2001).
The tissues most commonly affected by mtDNA mutations and subsequent disorders are those
that are normally affected by aging, i.e. brain, heart, skeletal muscle, kidney and the endocrine
system (Wallace, 2005). It has been shown that there is a correlation between aging and the
presence of the mitochondrial common deletion in skeletal muscle, however, to date mutations in
the mtDNA control region have not been investigated. As previously stated, the mtDNA control
region contains the origin of replication of the heavy strand, two initiation sites for transcription
of the heavy strand mtDNA, the promoter for transcription of the light strand, and the primary
and secondary initiation sites for heavy strand synthesis. In order to examine potential age
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associated effects in skeletal muscle, we have established distinct age groups in the rhesus
macaque that correlate to human reproductive ages. We compared the mtDNA control region
sequences to a known rhesus macaque mtDNA sequence in order to determine if there were any
significant changes associated with age.
One primary difference between nuclear DNA and mtDNA are the replication repair
mechanisms present in the two genomes. It has been determined that the spontaneous mutation
rate in mtDNA is more than two orders of magnitude higher than what is typically observed in
nuclear DNA (Khrapko et al., 1997). Mitochondrial DNA do not have histones and there is only
one known repair mechanism, the 3’-5’ exonuclease function that is part of the only known
mitochondrial polymerase, PolG.

It is widely thought that the limited repair function is

responsible for the high mutation rate seen in mtDNA. It has been shown that when the
catalytic subunit of the mitochondrial polymerase, PolG, is knocked out it results in embryonic
lethality in mouse embryos which causes early developmental arrest between embryonic days 7.5
and 8.5, associated with severe mtDNA depletion (Hance et al., 2005). Additionally, when
homozygous knock-in mice that expressed a proof-reading-deficient version of PolGA, the
catalytic subunit of PolG, were created, the mice developed an mtDNA mutator phenotype with a
3-5 fold increase in the levels of point mutations, as well as increased amounts of deleted
mtDNA (Trifunovic et al., 2004). This increase in somatic mtDNA mutations is associated with
reduced lifespan and premature onset of age-related phenotypes (Trifunovic et al., 2004).
Considering how critical PolG is to mtDNA replication, we felt it was important to determine if
mtDNA mutations in the catalytic subunit of PolG, as well as the region of such importance
identified by Trifunovic et. al., are present in the same skeletal muscle samples used to determine
if there are age related mutations in the mtDNA control region.
The final aim of this study was to determine if meiotic arrest of NHP oocytes is
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correlated to mutations within the mtDNA control region. It has been proposed that in oocytes
and preimplantation embryos accumulation of mtDNA mutations in the mitochondrial genome
contributes to impaired metabolic function and thus to developmental incompetence (Barritt et
al., 1999; Barritt et al., 2000b; Brenner et al., 1998; Chen et al., 1995; Keefe et al., 1995).
Oocytes have large numbers of mitochondria, as discussed Chapter 1, that can support essential
developmental processes such as oocyte growth and meiotic maturation.

When tissues

accumulate mtDNA rearrangements that reach a clinically significant threshold, the efficiency of
oxidative phosphorylation is reduced (Cortopassi and Arnheim, 1990). It is generally assumed
that there needs to be a sufficient number of normal mitochondrial genomes in order for the
oocyte to mature and the subsequent embryo to develop and implant; however, a relationship
between mitochondrial mutations and reproductive success is unproven. Therefore, we wanted
to determine whether there is an increasing percentage of mtDNA mutational load within the
control region corresponding to failure of oocytes to complete metaphase II of meiosis, enabling
them to be fertilized and poor embryo development.
We compared mtDNA control region sequences from arrested GV, arrested MI, normal
MII oocytes and preimplantation embryos within and among cohorts for mutations that may be
causing meiotic arrest and poor embryo quality.
Materials and Methods
Experiment 1
Collection of material
Initially, we established age groups in which all animals were assigned: 1) <5 (juvenile),
2) 6-10 (early reproductive), 3) 11-20 (late reproductive) and 4) 21 (aged). These age groups
were selected as they correlate to human reproductive ages. Establishment of these groups
enabled us to examine any age effects that may be occurring during the aging process. The
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rhesus macaque mtDNA control region, including the D-Loop, is approximately 1100bp long.
MtDNA control region specific primers were designed and synthesized by Sigma Genosys (The
Woodlands, TX, USA). Rhesus macaque skeletal muscle was collected by necropsy and flash
frozen in liquid nitrogen (LN2). Total DNA was extracted using a Puregene DNA purification
system (Gentra, Minneapolis, MN, USA). Mitochondrial specific primers were used to detect
the mtDNA control region, PolG catalytic subunit and PolG Exon 3. PCR reactions contained
100ng of total DNA in a 50µl reaction containing 1X Taq PCR buffer, 2.0mM MgCl2, 200µM
each dNTP, 0.5µM each forward and reverse primers and 1.25U Taq DNA polymerase. PCR
products were then submitted for direct sequencing. All sequences were performed using the
BigDye Terminator sequencing reactions, purification and the analysis system by Applied
Biosystems.
Experiment 2
Controlled Hormonal Ovarian Stimulation
The ovarian stimulation protocol has been previously described (Zelinski-Wooten et al.,
1995). Briefly, rhesus macaques were hormonally stimulated with a sequential regimen of
recombinant human gonadotrophins at either the Oregon National Primate Research Center
(ONPRC) and the Caribbean Primate Research Center (CPRC). Female rhesus macaques at the
ONPRC received rFSH (Organon, Oss, The Netherlands; 30 IU per injection, twice daily, IM)
for 7 days, followed by 2 days of rFSH and rLH (EMD Serono, Rockland, MA; 30 IU rFSH and
30 IU rLH per injection, twice daily, IM). During the final 3 days of the rFSH treatment,
animals also received the GnRH antagonist Acycline (0.075 mg/kg animal body weight) to
prevent a spontaneous LH surge. Ovarian stimulation of rhesus macaques at the CPRC was
performed by administration of rFSH (Organon, Roseland, NY; 37.5 IU per injection, twice
daily, IM) for 10 days. At both primate centers, on the final day of rFSH treatment, 32–33 hours
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before follicular aspiration, oocyte maturation was induced with a single injection of
recombinant hCG (750–1,000 IU, IM).
Oocyte and Sperm Collection, Insemination, and Embryo Culture
Procedures for oocyte recovery, sperm collection, insemination, and embryo culture have
been described previously (Bavister et al., 1983a; Boatman and Bavister, 1984; Wolf et al.,
1989). Briefly, follicular fluid was collected in TALP-HEPES containing 0.3% bovine serum
albumin (BSA). The aspirates were sifted through a cell strainer and oocytes were collected after
rinsing the filter. After cumulus removal using hyaluronidase (0.03%), oocytes were rinsed,
meiotic stage was determined (GV, MI or MII) and placed in these groups in TALP medium
culture drops supplemented with BSA, (Bavister and Yanagimachi, 1977), and incubated in 5%
CO2 in air at 37°C. GV, MI and half of the cohort of MII oocytes were stripped of their zonae
pellucidae with acid Tyrode’s solution (Sigma-Aldrich, St. Louis, MO, USA).

They were

individually placed into 0.2 ml PCR tubes with 3 ȝl of 0.1% polyvinyl alcohol (PVA) in
phosphate buffered saline (PBS). Samples were stored at -20°C until use. Semen was obtained
by electroejaculation (Mastroianni and Manson, 1963) and seminal plasma was removed
according to standard protocols. Spermatozoa were activated with dbcAMP and caffeine (1 mM
each) and used for insemination of the remaining MII oocytes at a final concentration of 1.5–
2.0×105 sperm/mL. The presence of pronuclei was assessed 18–20 hours after insemination.
Presumptive zygotes were transferred to amino acid-supplemented HECM-9 culture drops
(McKiernan and Bavister, 2000) and incubated under a 5% CO2 in air atmosphere at 37°C until
day 3. Approximately 72hrs post insemination embryos were frozen in the same manner as the
rest of the cohort of oocytes.
Embryos and oocytes (denuded of cumulus cells using 10mg/ml hyaluronidase dissolved
in TL-HEPES) were stripped of their zonae pellucidae with acid Tyrode’s solution (Sigma-
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Aldrich, St. Louis, MO, USA). They were individually placed into 0.2 ml PCR tubes with 3 ȝl
of 0.1% polyvinyl alcohol (PVA) in phosphate buffered saline (PBS). Samples were stored at 20°C until use. Prior to PCR, 3 ȝl of a mixture of 4x10-4 M sodium dodecyl sulfate (SDS;
Sigma-Aldrich) and 125 ȝg/ml proteinase K (Roche Diagnostics Corp, Indianapolis, IN, USA)
were added to each tube for cell lysis. The tubes were incubated at 37°C for 1 hr, and then
heated to 95°C for 15 min to inactivate proteinase K.
The gene-specific oligonucleotide primers used in this study were synthesized by Sigma
Genosys (The Woodlands, TX, USA). To amplify the internal control mtDNA region and the
rhesus common deletion simultaneously, the DNA was divided into two 3ȝl aliquots prior to
PCR amplification. Each aliquot was amplified using a MyCycler Thermal Cycler (Bio-Rad,
Hercules, CA, USA) in a 25 ȝl reaction volume containing 1.5 mM MgCl2, 1 IU Taq
polymerase, 200 ȝM each dNTP and 0.5 ȝM gene-specific primers using the following
amplification profile for all reactions (annealing temperature specific for each primer pair): an
initial denaturation of 95ºC for 2 min, followed by 30 cycles of 95ºC for 30s, annealing for 30s
and primer extension for 1min at 72º C, with a final extension of 72ºC for 5min. PCR products
were then submitted for direct sequencing. All sequencing was performed using the BigDye
Terminator sequencing reactions, purification and the analysis system by Applied Biosystems.
Sequence Analysis
Sequence analysis was performed on all rhesus macaque skeletal muscle, oocytes and
embryos from IVP. Only sequences with a quality of Q20 or greater were used for analysis. For
control region and PolG sequence analysis, consensus sequences were created for each skeletal
muscle sample for both regions of interest. For oocyte and embryo sequence analysis, consensus
sequences were created for each animal and oocyte group, (i.e. Animal 18879 GV) and
compared to each other and the mtDNA control region of the Macaca Mulatta mitochondrion

57
complete genome (NCBI Accession AY612638) using Sequencher Software by Gene Codes Inc.
Results
Rhesus Macaque Skeletal Muscle Sequencing
A total of 18 rhesus macaque skeletal muscle samples were collected and assigned to
each of the four age groups: 1(n=7), 2(n=4), 3(n=4) and 4(n=3). Due to the limited number of
aged animals in captivity, group 4 had the lowest number of samples available. MtDNA
consensus sequences from both skeletal muscle and reproductive material were compared to the
mtDNA control region of the Macaca Mulatta mitochondrion complete genome (NCBI
Accession AY612638) and to each other. One area within the mtDNA control region became an
area of interest once all samples were compared.

Figure 10: Region of interest within the mtDNA control region. All sequences are identified by
the age of the animal at the time of death and aligned to control sequence.
From mtDNA nucleotides 251-252 insertion of an ACACC repeat ranging from 1-5
repeats were found in 5 samples (Figure 10). This region corresponds to the H-Strand promoter
region and a TFAM binding site. This insertion was seen in three samples in age group 1, one
sample in age group 2 and one sample in age group 4 (Table 4). There was no correlation
between advanced aging and this insertion. In fact, three out of seven samples in the youngest
age group (group 1) were found to harbor this insertion (Table 4). The muscle sample from the
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29 y.o. animal had an extremely high rate of point mutations, insertions and deletions (Appendix
1).
Table 4: Number of skeletal muscle samples analyzed in each of the four age groups and number
of samples that exhibited the insertion in the TFAM binding site in each of the four age groups.
# samples
# samples with insertions

Group 1

Group 2

Group 3

Group 4

7
4

4
1

4
0

3
1

All 18 skeletal muscle samples analyzed for mtDNA control region inserts were also
analyzed for mutations within the catalytic subunit of the mitochondrial polymerase, PolG. We
found no consistently exhibited mutations in the catalytic subunit and no correlation between
advance age and accumulation of mutations (Appendix 2).
Rhesus Macaque Oocyte and Embryo Sequencing
Oocytes from 5 rhesus IVF cycles and embryos from 2 rhesus IVF cycles were analyzed
(Table 5).
We found no correlation between meiotic arrest during oocyte maturation and mtDNA
control region mutations (Appendix 3). We believe the lack of correlation between aging and
oocyte maturation to mtDNA control region mutations indicates there are other factors
influencing the aging phenotype as well as meiotic arrest during oocyte maturation.
Table 5: Number of oocytes and embryos sequenced from each animal.
GV
MI
MII
Day 3 Embryos

18879

19733

21129

21176

22031

Total

5
-

7
8
7
8

3
5
5
4

4
4
-

3
5
-

10
20
26
12

Discussion
The purpose of this specific aim was threefold: 1) to determine if there are mutations in
the mtDNA control region associated with the aging phenomenon, 2) to determine if there are
mutations in the catalytic subunit of the mitochondrial polymerase, PolG, associated with aging,
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and 3) to determine if there are mutations in the mtDNA control region associated with failure of
oocytes to resume meiosis and develop to a fully mature state, (MII), enabling them to be
fertilized. We sequenced the mtDNA control region of 18 rhesus macaque skeletal muscle
samples from animals ranging in age from 1-31 year. We found no correlation between aging
and the accumulation of mtDNA point mutations within the mtDNA control region. One muscle
sample from an aged animal (29 y.o.) that we analyzed did contain numerous deletions,
insertions and point mutations within the mtDNA control region (Appendix 1). This sample was
from the same 29 year old male rhesus macaque that was analyzed by Gokey (Gokey et al.,
2004). They too found that this animal contained numerous mtDNA breakpoints and deletions
throughout the mtDNA genome. However, we also analyzed 2 other skeletal muscle samples
from aged animals (31 y.o. and 21 y.o.) and found no point mutations in common with the 29
y.o. This indicated that point mutations and mtDNA control region deletions can accumulate
with age, however it may be due to susceptibility of the individual animal and not due to the
aging phenomenon. This hypothesis is supported by the fact that three out of seven samples
analyzed that were from animals under 5 years of age showed multiple insertions and point
mutations within the same region (bp 251-252), to those seen in the sample from a 29 y.o. animal
(Appendix 1). These animals may have been susceptible to mtDNA damage from a very young
age and therefore likely would have accumulated more mutations as they aged due to clonal
expansion of mutant mtDNA genomes, not necessarily due to the aging process causing mtDNA
damage over time.
We sequenced the catalytic subunit of the mitochondrial polymerase, PolG, of all 18
samples sequenced for the mtDNA control region. PolG is encoded in the nucleus and contains
two subunits: a large catalytic subunit that harbors the 3’-5’ exonuclease and 5’deoxyribose
phosphate (dRP) lyase activities, and a smaller accessory subunit which increases both the
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catalytic activity and processivity of the catalytic subunit. Diseases such as PEO, KSS, Alpers
syndrome and ataxia, as well as symptoms of premature menopause, progressive muscle
weakness, parkinsonism, and male infertility are coupled with mutations in human PolG (Luoma
et al., 2004; Mancuso et al., 2004; Naviaux and Nguyen, 2004; Van Goethem et al., 2001;
Zeviani et al., 1988; Zeviani et al., 1989). Two particular studies led us to examine the catalytic
subunit of PolG in the rhesus. First, Trifunovic found that homozygous knock-in mice that
expressed a proof-reading-deficient version of the catalytic subunit of PolG developed an
mtDNA mutator phenotype with a 3-5 fold increase in the levels of point mutations, increased
amounts of deleted mtDNA as well as reduced lifespan, weight loss, reduced subcutaneous fat,
hair loss, curvature of the spine, osteoporosis, anaemia, reduced fertility and heart enlargement;
all factors seen due to aging (Trifunovic et al., 2004). Secondly, Hance found that when the
PolG catalytic subunit is knocked out it results in embryonic lethal and PolG deficiency in mouse
embryos which causes early developmental arrest between embryonic days 7.5 and 8.5,
associated with severe mtDNA depletion (Hance et al., 2005). While both of these studies were
in mice and knock-out primates have yet to be developed, we felt it relevant to determine if there
were any mutations in the rhesus catalytic subunit of PolG, associated with aging, that were
detectable in tissue from rhesus macaques at different ages. We found no correlation between
accumulation of mutations in the catalytic subunit of PolG and the aging phenomenon (Appendix
2).
We sequenced the mtDNA control region of 10 arrested GV oocytes, 20 arrested MI
oocytes and 28 normally maturing MII oocytes from 5 rhesus macaques (Table 5). We found no
consistently exhibited point mutations or deletions in either GV, MI or MII oocytes, indicating
that the failure of oocytes to complete MII of meiosis is not caused by alterations in the mtDNA
control region (Appendix 3). Furthermore, we found no consistently exhibited point mutation or
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deletions in day 3 embryos that originated from normal MII oocytes, indicating that there are
likely no changes or mutations to the mtDNA control region during fertilization and early
embryo development. Due to the limited number of samples analyzed, we agree that these
findings are not statistically significant and do not lead to conclusions about either the
involvement, or lack there of, of either the mtDNA control or PolG to the aging process or
meiotic failure. The DNA sequencing methods available at the time of this study were limited,
especially considering the complex, technologically advanced methods that have recently been
developed. Furthermore, we did not sequence the entire mtDNA genome of any sample, however
we feel the analysis of the control region, which is the location where numerous process involved
in mtDNA replication and transcription (Table 6), may indicate that the specific sequence of the
mtDNA control region may not be critical to the process of meiotic maturation of oocytes.
Table 6: Sites within the mtDNA control region and base pair locations.
Function
Control Region with D-Loop
Hypervariable Region I
Termination Sequence
Control Element
L-strand Control Element
Hypervariable Region II
H-strand Replication Origin
Conserved Sequence Block I
TFAM Binding Site
TFAM Binding Site
Conserved Sequence Block II
Replication Primer
Conserved Sequence Block III
H-strand Control Element
H-strand Control Element
L-strand promoter
TFAM Binding Site
TFAM Binding Site
Major H-strand Promoter

Location
16024-576
16024-16383
16157-16172
16194-16208
16499-16506
57-372
110-441
213-235
233-260
276-303
299-315
317-321
346-363
371-379
384-391
392-445
418-445
523-550
545-567
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CHAPTER 5
SPECIFIC AIM 4
Introduction
Specific Aim 4: To determine if gonadotrophin stimulation efficiency can be improved
through optimization of gonadotrophin stimulation protocols.
Our laboratory has been working with the Caribbean Primate Research Center (CPRC)
for approximately 4 years in an effort to establish a reputable rhesus macaque IVF program in
order to pursue developmental biology grants and research projects using the CPRC as a resource
to provide high quality rhesus oocytes, embryos and sperm. In order to obtain rhesus macaque
reproductive material of the highest quality, we worked onsite with the current staff at CPRC in
order to improve the efficiency of the IVF program. Through previous collaboration with other
primate research centers and upon working with CPRC, it became apparent that a significant
inefficiency of the IVF program was the gonadotrophin stimulation regimen to which the
monkeys were subjected. Individual NHP respond differently to gonadotrophin stimulation in
the same manner that individual humans respond differently.

The previous gonadotrophin

stimulation protocol that was employed at the CPRC was as follows: 37.5IU rFSH twice daily
for 10 days with 1000IU recombinant (rhCG) given on day 10 and oocyte collection 34 hours
later. While this protocol worked intermittently, it generally resulted in a mediocre rate of
mature oocytes (MII) upon collection and a high rate of GV oocytes. Therefore the objective of
this specific aim was to identify and implement methods of gonadotrophin stimulation in order to
improve upon the efficiency of rhesus macaque IVF at the CPRC.
Material and Methods
Controlled Hormonal Ovarian Stimulation
Ovarian stimulation and oocyte recovery was adapted from previously described
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protocols (Schramm and Bavister, 1999). Briefly, rhesus macaque females were observed for
signs of menstrual activity and subjected to follicular stimulation via intramuscular injections of
(rFSH). Prior to this study, monkeys at the CPRC received 37.5 IU of rFSH twice daily, for 10
days.

On the final day of rFSH treatment, 34 hours before follicular aspiration, oocyte

maturation was induced with a single injection of 1000 IU recombinant hCG.
Oocyte Collection and Meiotic Stage Determination
Procedures for oocyte recovery, sperm collection, insemination, and embryo culture have
been described previously (Bavister et al., 1983a; Boatman and Bavister, 1984; Wolf et al.,
1989). Briefly, follicular fluid was collected in TALP-HEPES containing 0.3% bovine serum
albumin (BSA). The aspirates were sifted through a cell strainer and oocytes were collected after
rinsing the filter. After cumulus removal using hyaluronidase (0.03%), oocytes were rinsed,
meiotic stage was determined (GV, MI or MII) and placed in these groups in TALP medium
culture drops supplemented with BSA, (Bavister and Yanagimachi, 1977), and incubated in 5%
CO2 in air at 37°C.
Experiment 1: Reduction of FSH dose
Due to the high cost of rFSH used for gonadotrophin stimulation protocols, we wanted to
determine if there was a significant reduction in the number of oocytes collected when the total
daily dose of rFSH was reduced by half. Animals continued to receive injections twice daily,
however instead of 37.5IU rFSH in each injection (75IU daily), animals received 18IU rFSH in
each injection (36IU daily). Follicular aspiration was performed as described above and numbers
of oocytes collected was recorded. Data from a total of 40 stimulation cycles was included in
this comparison; 21 cycles using a high rFSH dose (75IU daily) and 19 cycles using a low rFSH
dose (36IU daily). Comparisons were made using a paired t-test and results were considered
statistically significant at  0.05.
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Experiment 2: Addition of rLH
Recombinant luteinizing hormone (rLH) is commonly used in both human and NHP
gonadotrophin stimulation protocols in an effort to mimic the acute rise and fall of LH seen in
the natural cycle, which initiates ovulation. In this study, monkeys were given 15IU rLH on the
evening of day 9 of rFSH stimulation and 15IU rLH on both the morning and evening of day 10
(30IU total on day 10). Follicular aspiration was performed as described above and numbers of
GV, MI and MII oocytes collected was recorded. Data from a total of 40 stimulation cycles was
included in this comparison: 24 cycles without LH and 16 cycles with LH. Comparisons were
made using a paired t-test and results were considered statistically significant at  0.05.
Experiment 3: Replacement of recombinant hCG with biological hCG
Human chorionic gonadotrophin (hCG) is widely used in both human and NHP IVF to
induce ovulation during gonadotrophin stimulation. Generally, a synthetically derived form of
hCG (Ovidrel) is used instead of biologically derived forms. Multiple NHP IVF programs have
had great success with recombinant hCG (rhCG), however, at the CPRC, cycles using rhCG
typically produced inconsistent numbers of mature oocytes, with a consistently large number of
oocytes remaining at the GV phase of meiosis. As previously discussed, oocytes must reach the
meiotic stage of MII in order for fertilization to occur, thus, GV oocytes are not capable of being
used for IVF related studies. Therefore, we replaced recombinant hCG with a biologically
derived form (Pregnyl). The same dose (1000IU) and timing of injection were used in all cycles.
Follicular aspiration was performed as described above and numbers of GV, MI and MII oocytes
collected was recorded.

Data from a total of 40 stimulation cycles was included in this

comparison: 24 cycles using recombinant hCG and 16 cycles using biological hCG.
Comparisons were made using a paired t-test and results were considered statistically significant
at  0.05.
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Results
Experiment 1: Reduction of rFSH dose: The average number of oocytes collected in the
high rFSH group was 20.4 oocytes per collection, while the average number of oocytes collected
in the low rFSH group was 20.8 oocytes per collection. Figure 11 shows that the reduction of the
previously used dosage of rFSH (75IU) to approximately half (36IU) resulted in no significant
difference in the average number of oocytes collected per stimulation.

Figure 11: Comparison of average number of oocytes collected per stimulation using either high
FSH (75IU daily) (n=21) or low FSH (36IU daily) (n=19).

Experiment 2: Addition of LH: When comparing the average percentage of MII, MI and GV
oocytes collected per stimulation, we found no significant differences between stimulations with
LH or without LH. While there was no significant difference found in the number of MII, MI or
GV oocytes collected, there was an observable trend in the number of MII and GV oocytes
collected (Figure 12) that we feel will become significant with the inclusion of data from more
cycles.

66

Figure 12: Average percentage of MII, MI and GV oocytes collected, per stimulation, without
LH (n=24) compared to the average percentage of MII, MI and GV oocytes collected, per
stimulation, with LH (n=16). Standard error bars are shown.
Experiment 3: Replacement of recombinant hCG with biological hCG: We found that the use of
a biological hCG resulted in a significantly higher average percentage of oocytes resuming
meiosis and completing germinal vesicle breakdown (GVBD).

In Figure 13, we show a

statistically significant increase in the average percentage of MII oocytes collected, as well as a
statistically significant decrease in the average percentage of GV oocytes collected due to the
replacement of R-hCG with B-hCG.

Figure 13: Average percentage of MII, MI and GV oocytes collected, per stimulation, with
recombinant hCG (n=24) compared to the average percentage of MII, MI and GV oocytes
collected, per stimulation, with biological hCG (n=16). Standard error bars are shown. Statistical
significance: a,b  0.05.
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Finally, we found that the combination of the protocol changes in Experiment 2 and 3,
i.e. the addition of rLH and the use of biological hCG, resulted in a statistically significant
increase in the average percentage of MII oocytes collected, as well as a statistically significant
decrease in GV oocytes collected (Figure 14).

Figure 14: Average percentage of MII, MI and GV oocytes collected, per stimulation, without
LH and using recombinant hCG (previous standard protocol) (n=22) compared to the average
percentage of MII, MI and GV oocytes collected, per stimulation, with LH and using biological
hCG (n=14). Standard error bars are shown. Statistical significance: a,b  0.05.
Discussion
The objective of this study was to identify and implement methods of gonadotrophin
stimulation in order to improve upon the efficiency of rhesus macaque IVF at the CPRC. This
was accomplished by 1) reducing the dose of rFSH, yet maintaining the number of oocytes
collected per stimulation, thus reducing the overall cost per stimulation cycle; 2) by significantly
increasing the number of meiotically “normal” (MII) oocytes collected that can be used in IVF
related studies; and 3) by significantly reducing the number of meiotically “abnormal” (GV)
oocytes collected that are unable to be used for IVF studies. The high dose of rFSH (75IU) used
in the previous protocol, while occasionally resulting in higher oocyte numbers (data not shown),
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also resulted in a significantly larger number of immature oocytes, which generally cannot be
used for IVF experiments. While the trend in human IVF has been to collect as many oocytes as
possible, embryologists and scientists are beginning to recognize the importance of quality
oocytes over simply large cohorts. We have shown that reducing the rFSH dose by half has no
significant difference on the average number of oocytes collected per stimulation (Figure 11).
The inclusion of rLH in gonadotrophin stimulation protocols is a common practice in
both human and NHP IVF programs. However, until this study, it was not used at CPRC and it
was unknown if there would be any benefit to adding it to the current protocol. While we were
not able to find that the addition of rLH alone significantly increased the number of MII oocytes
collected, we did find that the combination of the inclusion of rLH, as well as replacing
recombinant hCG with biological hCG, did result in significantly increased numbers of MII
oocytes collected, as well significantly decreased numbers of GV oocytes collected (Figure 14).
This is the first study to show that, not only does B-hCG increase the number of oocytes
collected after gonadotrophin stimulation that reach meiotic maturity (MII), thus allowing more
oocytes to be used for IVF experiments, but this is also the first study to show that monkeys can
be subjected to more than one dose of B-hCG without becoming refractory to the drug itself. It
is well known that rhesus macaques can only be subjected to one stimulation cycle of biological
FSH before becoming refractory to FSH stimulation, resulting in a complete lack of ovarian
response and follicle development. This is the reason why most protocols use a recombinant
form of FSH, as we have used throughout this study, in order to stimulate each animal multiple
times. The practice of using an animal for multiple stimulation protocols is well established and
reduces the number of animals needed for experimentation. Concomitantly, it has been assumed
that a typical refractoriness would be seen with biological hCG as has been historically seen with
biological FSH. However, we have found that animals can be given biological hCG up to three
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times with no detrimental effect to the process of ovulation (data not shown). Furthermore, we
have shown here that biological hCG significantly increases the number of meiotically “normal”
oocytes (MII) collected as well as reducing the number of unusable oocytes (GV). The changes
to standard IVF protocols we have used in this study will enable the collection of higher quality
reproductive material to be used for future research projects as well as reducing unusable
material and the overall cost of reproductive research in the rhesus macaque.

70
CHAPTER 6
SPECIFIC AIM 5
Introduction
Specific Aim 5.1: To determine if expression levels of genes controlling mitochondrial
dynamics are correlated to the failure of oocytes to resume meiosis.
Specific Aim 5.2: To determine if expression levels of genes controlling mitochondrial
dynamics are correlated to important preimplantation development time points.
Interest in the mitochondrion and its role in the preimplantation mammalian embryo has
had a recent resurgence (Bavister and Squirrell, 2000; Van Blerkom, 2000). Prior studies have
shown that mitochondria are initially morphologically immature; spherically shaped rather than
elongated, with relatively few cristae; and undergo a maturation process prior to blastocoel
formation. The general process of mitochondrial maturation has been described for multiple
species; mouse (Hillman and Tasca, 1969); pig (Hyttel and Niemann, 1990); bovine (Plante and
King, 1994) and primates (Panigel et al., 1975). It is also understood that mitochondria undergo
a variety of species-specific reorganizations during early preimplantation development.
Mitochondria in hamster embryos reorganize from a homogeneous distribution in the oocyte to a
distinct perinuclear organization late in the pronucleate and two-cell stages (Barnett et al., 1996).
Mitochondrial distribution has also been associated with developmental competence in multiple
species including hamster (Barnett et al., 1997; Lane and Bavister, 1998; Squirrell et al., 2001);
mouse (Muggleton-Harris and Brown, 1988); pig (Hyttel and Niemann, 1990) and cattle (Van
Blerkom et al., 1990). It has been shown that in oocytes and early cleavage stage embryos in
multiple species, including hamster and mouse (Van Blerkom, 1991), that mitochondria have a
distinct pronuclear translocation and that perturbations from these patterns result in embryonic
lethality. Human zygotes have shown a pronuclear accumulation of mitochondria (Noto et al.,
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1993; Van Blerkom et al., 2000), as well as significantly different mitochondrial localization
patterns between individual oocytes between and among cohorts.

Furthermore, pronuclear

oocytes that showed a pronounced asymmetrical mitochondrial distribution during syngamy
continued to show an asymmetrical distribution after the first cell division, and between
blastomeres throughout embryo development. When analyzed individually, the blastomeres
containing less mitochondria also had lower ATP content compared to blastomeres with higher
mitochondrial content (Van Blerkom et al., 2000). Additional studies in the rhesus have shown
that zygotes exhibit a distinct organization of mitochondria that accumulate between the male
and female pronuclei, similar to the human (Squirrell et al., 2003). There is also marked
difference is the heterogeneity of mitochondrial organization among oocytes, which may reflect
the heterogeneity of oocyte quality and developmental competence in primates, unlike
homogeneity in hamsters (Barnett et al., 1996).

It is possible that the localization of

mitochondria in rhesus zygotes is a result of mitochondria undergoing fusion and fission
processes during preimplantation resulting in what appears to be the microtubule network
guiding the mitochondria to their pronuclear location. It has also been shown that the pronuclear
accumulation of mitochondria in rhesus oocytes is transient, on the order of a few hours,
although the exact length of time remains uncertain (Squirrell et al., 2003).
It is well established that during the early stages of development, embryo competence
depends upon ATP produced by mitochondria inherited from the mother. During the early
stages of embryo development, energy is produced by OXPHOS via amino acids, lactate and
pyruvate, with the glucose pathway proving to be harmful at this stage; indicating that a
threshold of mitochondrial activity is necessary to support energetic demands (Tarazona et al.,
2006).

Once embryonic genome activation begins, the metabolic activity of the embryo

increases as it becomes capable of using alternative pathways such as anaerobic glycolysis,
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allowing mitochondrial activity to decrease. While the lack of mitochondrial organization has
been correlated to poor embryo development and poor implantation in the human (Scott and
Smith, 1998), the exact influence of mitochondrial distribution on embryo competence remains
to be determined.
The molecular analysis of mitochondrial dynamics began in 1997 with the identification
of the Drosophila mitofusin gene Fzo (Hales and Fuller, 1997). Fzo is a mitochondrial outer
membrane GTPase required for mitochondrial fusion during spermatogenesis. The core genes
mediating mammalian mitochondrial fusion are Mfn1, Mfn2 and Opa1. Mfn1 and Mfn2, the
mammalian homologues to Fzo, are large GTPases with similar homology and topologies that
reside on the outer mitochondrial membrane (Chen and Chan, 2004). Opa1 is an inter membrane
space protein and is also essential for fusion (Detmer and Chan, 2007). The exact relationship
between these proteins remains unclear, however cells lacking any of the three proteins have
been shown to have inhibited respiratory capacity. Additionally, the contact between the inner
and outer membranes, where these proteins reside, is essential to mitochondrial fusion (Detmer
and Chan, 2007). The core genes mediating mitochondrial fission are Drp1, Fis1 and MTP18.
Drp1 is a large dynamin related GTPase located primarily in the cell cytosol. A portion of Drp1
moves to the mitochondrial tubule where it interacts with Fis1 (Parone and Martinou, 2006),
which is a transmembrane protein anchored to the mitochondrial outer membrane. Both Drp1
and Fis1 have been implicated in mitochondrial outer membrane permeability and mediate
downstream apoptosis (Chen and Chan, 2004). Inhibition of Drp1 has been shown to delay
mitochondrial division and partially inhibit apoptosis. MTP18 is a mitochondrial protein that
contributes to the balance of mitochondrial fission and fusion. Changes in the expression levels
of MTP18 interfere with the balance of mitochondrial fission and fusion; whereas loss results in
increased mitochondrial fusion and an increase results in increased number of fragmented
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mitochondria (Tondera et al., 2005). As previously stated, mitochondria move along both
microtubules and actin, using microtubule-based molecular motors for long distance movements
(Morris and Hollenbeck, 1995). Distribution of mitochondria varies in response to multiple
regulatory cues such as energy requirements, growth factors and mitochondrial membrane
potential (Chada and Hollenbeck, 2004; Miller and Sheetz, 2004; Morris and Hollenbeck, 1993).
Mutations in either of two of the components identified to be important for transport; Milton
(Stowers et al., 2002) and Miro (Guo et al., 2005) appears to abolish anterograde mitochondrial
transport. It has been shown (Glater et al., 2006) that kinesin, Milton, and Miro work together in
anterograde transport and that Milton attaches kinesin to mitochondria through Miro. Pink1, a
putative serine–threonine kinase that localizes to the outer mitochondrial membrane, has been
shown to have a role in cellular protection against oxidative stress and to affect mitochondrial
dynamics. Recent ndings have shown that Pink1 interacts with the Miro/Milton complex and
that overexpression of either Miro or Milton can suppress mitochondrial fragmentation induced
after Pink1 silencing (Weihofen et al., 2009).

Pink1 and Parkin, a gene associated with

Parkinson’s disease, are linked in a common pathway that is involved in the protection of
mitochondrial integrity and function (Pridgeon et al., 2007). Our lab has recently found that
monkey oocytes have an abundance of Miro1 and 2, Milton, Pink1, Parkin, Mfn1, Mfn2 and
Drp1 (unpublished data). Therefore we speculate that mitochondrial trafficking is important for
fusion and fission mechanisms and may impact oocyte and embryo quality.
Materials and Methods
Ovarian Stimulation, Oocyte Recovery and In Vitro Fertilization
All supplies were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise
indicated. Ovarian stimulation and oocyte recovery was adapted from previously described
protocols by Schramm et al (Schramm and Bavister, 1999). Briefly, rhesus macaque females
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were observed for signs of menstrual activity and subjected to follicular stimulation via
intramuscular injections of (rFSH) as follows; Days 1-10 rFSH twice daily; day 9 (P.M.), (rLH)
once and day 10 rLH twice (A.M. and P.M.). On the night of the 10th day, the animal was
injected with bhCG. The employment of rLH in this manner was to mimic the endogenous surge
of LH followed by hCG. Procedures for oocyte recovery, sperm collection, insemination, and
embryo culture have also been described previously (Bavister et al., 1983a; Boatman and
Bavister, 1984; Wolf et al., 1989). Briefly, follicular fluid was collected in TALP-HEPES
containing 0.3% bovine serum albumin (BSA). The aspirates were sifted through a cell strainer
and oocytes were collected after rinsing the filter. After cumulus removal using hyaluronidase
(0.03%), oocytes were rinsed, meiotic stage was determined (GV, MI or MII) and oocytes were
placed in these groups in modified CMRL medium and incubated in 6% CO2 in air at 37°C.
Rhesus semen was collected by penile electroejaculation (Lanzendorf et al., 1990). Sperm count
and motility analyses were performed, spermatozoa cleaned with TL-HEPES medium,
resuspended and stored in TALP and allowed to equilibrate in the incubator at 6% CO2 at 37°C
for at least two hours. Just before insemination, MI oocytes were examined for maturation and
oocytes were inseminated in three groups; MII, MI and MI matured to MII (MI-MII) before
insemination. This second assessment of oocyte maturation established a group of oocytes that
matured from MI to MII between the time of collection (33-34 hrs post hCG) and the time of
insemination (37-38 hours post hCG). Previous work in our laboratory (Dupont et al., 2009) has
shown that this period of time is important in chromosomal aneuploidy and mosaicism. All
oocytes were placed into equilibrated, modified TL within the three groups. Spermatozoa were
activated with dbcAMP and caffeine (1mM each) and used for insemination of all MII, MI and
MI-MII oocytes at a final concentration of 1.5–2.0×105 sperm/mL. Approximately 12-14 hours
later, presumptive zygotes were cleaned of sperm and placed into fresh TL for fluorescent
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imaging. To guarantee the removal of all granulosa cells and sperm, oocytes were aspirated with
plastic stripper tips (Mid Atlantic Diagnostics, Marlton, NJ, USA).
For oxygen concentration studies, all oocytes were inseminated under high O2 levels (6%
CO2/20% O2). Fourteen hours after insemination, presumptive zygotes were randomly placed in
amino acid-supplemented HECM-6 culture drops (Schramm and Bavister, 1996) and incubated
under either high O2 (6% CO2/20% O2) or low O2 (6% CO2 /5% O2 /89% N2) at 37°C until day 3.
All embryos used for the oxygen concentration study originated from MII oocytes at the time of
collection in order to eliminate the possibility of maturation stage differences.
Imaging
For zygotes: 13 hours post-insemination, zygotes exhibiting 2 pronuclei (2PN) were
placed into MitoTracker Orange CMTMRos (Molecular Probes), which passively diffuses across
the plasma membrane and accumulates in active mitochondria, as well as a nucleic acid stain,
Hoechst 33342. After incubation for 45 minutes, zygotes were rinsed through 3 drops of fresh
modified TL to remove excess stain, and immunofluorescence detection of mitochondrial
localization and nuclei was assessed using fluorescence microscopy.
For embryos: approximately 72 hours post-insemination, digital images of each embryo
was taken for assessment of quality grade.
Fluorescent and brightfield imaging was performed as quickly as possible in order to
prevent damage caused by exposure to light.
RNA Analysis and cDNA Synthesis
Immediately after either fluorescent or brightfield imaging, zygotes and embryos were
individually placed into cell lysis buffer according to the published protocol from the Stratagene
Absolutely RNA Nanoprep Kit (Stratagene, La Jolla, CA, USA), snap frozen in LN2 and stored
at -80oC to preserve RNA for later analysis. Following thawing on ice and according to the
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manufacturer’s instructions, RNA from the zygotes and embryos was extracted using the
Absolutely RNA Nanoprep Kit (Stratagene, La Jolla, CA, USA). Recovered RNA was reverse
transcribed into cDNA using random hexamers and Superscript III reverse transcriptase
(Invitrogen, San Diego, CA, USA) following instructions from the manufacturer.
Multiplex target specific preamplification of cDNA
Custom TaqMan gene expression assays for genes encoding mitochondrial fusion
(Mfn2), fission (Drp1), mitochondrial transport (Miro1 and Pink1) and mitochondrial replication
(SSBP1) that were previously designed in our laboratory were employed in this study. In
addition to these custom-made gene expression assays, a commercially available primer pair and
probe for eukaryotic 18S rRNA was purchased (Applied Biosystems, Foster City, CA, USA).
A multiplex PCR preamplification of 5 cDNA targets was performed in a final volume of
25ȝl using a commercial PreAmplification Mix (Applied Biosystems, Foster City, CA, USA)
according to manufacturer’s instructions. Because of its high abundance, the endogenous control
18S rRNA was not preamplified. Reaction mixtures were initially held at 95°C during 10 min
before 14 preamplification cycles of 15 sec at 95°C and 4 min at 60°C were executed. The
linearity of the preamplification was tested following quantitative real-time PCR of both
unamplified and diluted (1:20) preamplified 0.1 ng/ȝl rhesus macaque testis cDNA. Within the
unamplified and preamplified testes cDNA group, CT values from all the transcripts of interest
were compared to a randomly chosen reference gene out of the 5 genes of interest. The ǻCT
values for each gene were subtracted from each other and resulting values (ǻǻCT) were
indicative of the linearity of the preamplification. The ǻǻCT values approximating zero were
considered linear, whereas values exceeding two were regarded as undesirable. To guarantee the
linearity of the reference gene, the complete calculation was repeated using another reference
gene out of the 5 preamplified targets.
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Quantitative Real-Time PCR
Triplicate amplifications were conducted in a 10ȝl final reaction volume using the
7900HT Fast Real-Time PCR System. The reaction mixture contained 1x TaqMan Universal
Master Mix (Applied Biosystems, Foster City, CA, USA), 1x TaqMan Gene Expression Assay
(Applied Biosystems, Foster City, CA, USA) and 2.5 ȝl of preamplified cDNA. After an initial
hold at 95°C for 10 min, reaction mixtures underwent 40 cycles of 15 sec at 95°C and 1 min at
60°C.

In order to create the standard curves, ten-fold dilutions of diluted (1:1) 0.1 ng/ȝl

preamplified rhesus macaque testis cDNA were quantified on the same plate as diluted (1:20)
preamplified zygote cDNA. Following the amplification, the threshold and baseline values for
each gene were empirically determined and remained constant over all plates. The threshold
values from each transcript of interest were used to approximate RNA equivalents from the
standard curve. Following this extrapolation, each RNA equivalent was normalized to the nonpreamplified 18S RNA equivalent.
Results
Zygote Data Analysis
Zygotes originating from the three maturation groups (MI, MII, MI-MII) from eight
rhesus macaque females were analyzed in this study. Details of monkey oocytes from the three
maturation groups are summarized in Table 7.
Our initial goal was to correlate mitochondrial movement throughout the embryo during
syngamy with expression of genes known to control mitochondrial dynamics and movement.
While we were able to collect images of mitochondrial localization at the zygote stage that show
the heterogeneity of mitochondrial distribution in a population of NHP zygotes (Figure 15)
regardless of maturation status of the original oocyte (MI, MII or MI-MII), we were not able to
correlate these images with gene expression profiles.
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Table 7: Animal identification and numbers of zygotes used from each animal.
Animal ID MI
MII
MI-MII
98H
3
53O
2
15S
3
5
12S
4
80C
1
5
1
76P
5
M598
2
5
88J
5
1
Total
12
18
12

Figure 15: Mitotracker staining of 4 rhesus macaque zygotes, from 4 different animals, 14 hours
post insemination. Note the heterogeneity between the individual zygotes
Previous studies by Squirrell (Squirrell et al., 2003) employed the use of confocal
microscopy and multi-photon laser scanning microscopy (MPLSM).

Neither of these

technologies were available at the CPRC and therefore all images were taken using
epifluorescense, which does not allow pinpoint images of the cell to be taken. Because of the
limitations of epifluorescense and the available microscope, we cannot definitively say that
mitochondrial localization, i.e. perinuclear localization during syngamy, is correlated to the
expression of genes controlling mitochondrial dynamics and movement. However, mitochondria
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are most certainly going through fusion, fission and movement processes during fertilization and
syngamy as can be seen by the differences in mitochondrial morphology and localization in the
images. Further studies need to be performed using confocal or MPLS microscopy.
Due to the success of the gonadotrophin stimulation protocol (Chapter 5) and the high
percentage of MII oocytes upon collection, it was not possible to use equivalent numbers of
oocytes from each female for each maturation group. Therefore no comparisons were made
between animals and each zygote was treated individually within the three maturation groups;
MI (n=12), MII (n=18) and MI-MII (n=12) (Table 7). Using the Student-Neuman-Keuls Test,
that compares the means of all three maturation groups to each other, for each individiual gene of
interest, we found no significant differences in the relative expression levels of all 5 genes
between the three maturation groups (Table 8).
Table 8. Means and number of samples analyzed (N) for each maturation group for each gene of
interest
Maturation
N
Mfn2
Pink1
Drp1
Miro1
SSBP1
Group
MII

12

81.60

27.86

103.48

175.12

153.33

MI

12

72.54

15.17

62.16

90.05

103.58

MI-MII

18

34.53

11.34

35.26

43.63

52.67

0.414

0.356

0.295

0.234

0.196

Significance

Student-Neuman-Keuls Test was used to compare the means of the 3 maturation groups to each other,
for all 5 genes of interest. No significant differences found.

Expression analyses revealed all genes analyzed were highly correlated; indicating that
mitochondrial fusion (Mfn2), fission (Drp1), movement (Pink1, Miro1) and replication (SSBP1)
are all strongly (p<.001) associated with each other during syngamy and preimplantation
development (Table 9).
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Table 9: Pearson correlation analysis showing strong correlation between all 5 genes of interest
for all zygotes analyzed, regardless of maturation group.
Pink1
SSBP1
Pearson Correlation
1
.873**
Sig. (2-tailed)
.000
N
41
41
Pearson Correlation
.873**
1
SSBP1
Sig. (2-tailed)
.000
N
41
42
Pearson Correlation
.827**
.939**
Mfn2
Sig. (2-tailed)
.000
.000
N
41
42
Pearson Correlation
.933**
.893**
Drp1
Sig. (2-tailed)
.000
.000
N
41
42
Pearson Correlation
.980**
.871**
Miro1
Sig. (2-tailed)
.000
.000
N
41
42
**. Correlation is significant at the 0.001 level (2-tailed).
Pink1

Mfn2
.827**
.000
41
.939**
.000
42
1
42
.884**
.000
42
.789**
.000
42

Drp1
.933**
.000
41
.893**
.000
42
.884**
.000
42
1
42
.909**
.000
42

Miro1
.980**
.000
41
.871**
.000
42
.789**
.000
42
.909**
.000
42
1
42

Pearson Correlations with Sig.(2-tailed) indicating all p0.001 and N = total number of
samples analyzed regardless of maturation group.

Embryo Data Analysis
Embryos from 3 rhesus macaque females were used for this study. Fourteen hours after
insemination, embryos were places in either low O2 (n=12) or high O2 (n=12). Real-Time PCR
gene expression analysis of the same 5 genes analyzed in zygotes revealed no significant
difference between day 3 embryos cultured under low O2 versus high O2 (Figure 16 & Table 10).

Figure 16: Comparison of relative expression levels of genes involved in mitochondrial
dynamics and replication in day 3 embryos cultured under either low or high oxygen
concentration. Each gene is normalized to the internal control, ribosomal 18S. No significant
differences shown.
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Table 10: Genes involved in mitochondrial dynamics and replication in day 3 embryos cultured
under either low or high oxygen concentration.
Pink1
SSBP1
Mfn2
Drp1
Miro1

Oxygen Concentration

N

Mean

Std. Deviation

Std. Error

Low

11

1.09214

0.466822

0.140752

High

10

1.25179

0.393131

0.124319

Low

11

10.05574

3.627983

1.093878

High

11

9.06683

7.760284

2.339814

Low

11

6.79198

4.248865

1.281081

High

11

6.92026

2.357120

0.710698

Low

11

5.37615

2.296540

0.692433

High

11

5.93824

2.239771

0.675316

Low

10

3.77506

2.374944

0.751023

High

11

5.30295

2.076477

0.626081

Showing mean, samples analyzed (N), standard deviation and standard error of relative expression
levels of genes involved in mitochondrial dynamics and replication in day 3 embryos cultured
under either low or high oxygen concentration. Each gene is normalized to the internal control,
ribosomal 18S.

Preimplantation Development Analysis
Mature MII oocytes that were previously analyzed in our lab for the same 5 genes of
interest were included in this analysis. The inclusion of this data allowed comparison of three
distinct time points during preimplantation development; oocyte, zygote and day 3 embryo. All
material used for this analysis originated from mature MII oocytes at the time of collection in
order to eliminate the possibility of maturation stage differences. The data for all three groups of
interest were non-normally distributed and therefore a Krustal-Wallis one-way ANOVA by ranks
was used. Krustal-Wallis is a non-parametric method for testing the equality of population
medians among groups. It is identical to a one-way ANOVA with the data replaced by their
ranks. As shown, MII oocyte gene expression is at basal levels for all genes analyzed except for
Pink1 (Table 11). After fertilization and during syngamy (zygote stage) all genes increase 2-3
fold from levels seen in the oocyte (Table 11). By day 3 of embryo development, all genes have
decreased to levels still significantly higher than those seen in the oocyte (except for Mfn2 and
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Pink1), but also significantly lower than what is seen in the zygote. Table 11 and Figure 17
show the mean rank comparisons of each gene for the 3 developmental groups. All comparisons
are statistically significant (p<0.001) except for Mfn2 expression in oocytes vs. embryos.
Table 11: Mean rank using the Krustal-Wallis Test for each of the three maturation groups for
each gene.
Oocyte

Zygote

D3 Embryo

Oocyte vs
Zygote
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001

Oocyte vs D3
Embryo
0.172
0.002
0.004
0.186
< 0.001

Zygote vs D3
Embryo
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001

14.93
46.72
22.33
Mfn2
10.87
46.67
25.92
Drp1
28.07
44.67
14.58
Pink1
12.8
45.67
21.18
Miro1
8.4
46.39
30.67
SSBP1
15
18
12
N
Each sample analyzed, regardless of developmental time point (N=45) is ranked, using the relative
expression normalized to ribosomal 18S, from highest to lowest, and the mean of each time point is
compared to the mean of every other time point, for each individual gene. Each comparison is statistically
different for each comparison except for Mfn2 and Miro 1 in oocyte vs day 3 embryo.

Figure 17: Data depicting the Krustal-Wallis test using mean rank.
Finally, a small subpopulation of zygotes and embryos were found to have dramatically
higher levels of gene expression of all 5 genes of interest. As shown in Figure 18, scatterplots
reveal this is especially true in zygotes. Raw data from this subpopulation is shown in Table 12.
Expression of all five genes is highly correlated as shown in Table 9.
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Figure 18: Scatterplots of MII oocytes, zygotes and day 3 embryos that express dramatically
higher expression levels.
Table 12: Relative expression levels
Animal ID
Pink1
SSBP1
80C
25.048
8.417
80C
414.239
77.336
76P
89.272
5.908
76P
352.451
19.728
88J
37.299
10.218
88J
383.488
37.8
15S
48.645
10.963
561.784
15S
167.599
454.633
15S
77.312
73J
1.546
6.428
73J
17.592
482.643
Shown are samples with typical expression levels
same animal that fall within the subpopulation
expression levels (green).

Mfn2
Drp1
Miro1
25.944
11.157
31.397
260.978
372.071
473.345
39.87
42.226
80.255
97.429
44.904
127.845
32.213
23.881
32.37
174.988
103.61
371.384
41.01
29.486
29.973
274.333
493.693
1,183.635
277.142
465.973
477.528
3.494
7.101
3.514
111.949
220.513
385.024
(white) and matched samples from the
of samples with dramatically higher

Discussion
The suppositions of this aim were primarily based on previous work that showed the
accumulation of mitochondria between the male and female pronucleus in rhesus macaque
zygotes and the heterogeneity of mitochondrial localization in rhesus oocytes, zygotes and
embryos (Squirrell et al., 2003).

While that study did confirm the transient nature of

mitochondrial localization during NHP preimplantation development, it did not examine what
factors may be contributing to these mitochondrial movements. In the present study, we have
been successful in correlating expression of genes involved in mitochondrial dynamics and
movement, as well as mtDNA replication, with specific time points in preimplantation
development that have been previously shown to be important in mitochondrial activity.
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The hypothesis of this specific aim were twofold. Our initial hypothesis was that meiotic
stage and mitochondrial distribution after fertilization influence expression of genes involved in
mitochondrial dynamics. As previously discussed, in order for proper fertilization to occur, the
GV-stage oocyte, which is arrested at the diplotene stage of MI, must resume meiosis and reach
MII, with the extrusion of the first polar body. The use of standard ART protocols in human
infertility treatment can result in the failure of meiotic resumption in 15 – 27% of oocytes within
the standard 36 h after the administration of hCG (de Vos et al., 1999; Junca et al., 1995).
Immature oocytes (GV or MI) are generally collected at oocyte retrieval along with mature MII
oocytes. Typically, oocytes are collected 32-34 hours post hCG injection and cultured for
approximately 4 hours, after which, some MI oocytes will extrude a polar body, achieve MII and
subsequently be used for IVF. It is fairly common for immature MI oocytes from human IVF
cycles to fertilize and develop into morphologically normal embryos (de Vos et al., 1999; Huang
et al., 1999; Junca et al., 1995; Strassburger et al., 2004), however these embryos generally lead
to reduced pregnancy and live birth rates (de Vos et al., 1999; Vanhoutte et al., 2005).
Furthermore, previous studies have shown that embryos developed from oocytes with delayed
polar body extrusion display high rates of chromosomal abnormalities regardless of morphology
(Dupont et al., 2009). In this study, we determined expression levels of genes involved in
mitochondrial fusion (Mfn2), fission (Drp1), movement and transport (Pink1, Miro1) and
replication (SSBP1) in zygotes originating from mature MII oocytes, immature MI oocytes and
oocytes that matured during the window of time between collection and insemination (MI-MII)
(Table 7). We found no differences in gene expression levels in any of the five genes analyzed
between the three maturation groups (Table 8). It is assumed that oocytes that had not extruded
the first PB by the time of insemination (MI group) must have extruded it sometime while in the
presence of sperm, in order for fertilization and PN formation to have occurred. With these data,

85
we propose that oocyte maturation to MII, from the span of time between collection (33-34 hrs
post hCG) and insemination (37-38 hrs post hCG), while involved in chromosomal normality
and stability (Dupont et al., 2009), does not influence the mitochondrial contribution to the
processes of fertilization and syngamy.

Interestingly, we did find very strong correlations

between all genes analyzed. Indicating, for the first time, that mitochondrial fusion (Mfn2),
fission (Drp1), movement (Pink1, Miro1) and transcription (SSBP1) are all strongly (p<0.001)
associated with each other during syngamy and preimplantation development (Table 9).
Our secondary hypothesis in this specific aim was that oxygen concentration during
embryo culture influences expression of genes involved in mitochondrial dynamics. Cohorts of
zygotes from 3 different animals that all originated from MII oocytes upon collection were
randomly assigned to embryo culture in either high O2 (6% CO2 / 20% O2) or low O2 (6% CO2 /
5% O2 / 89% N2) until day 3. The same five genes that were analyzed in zygotes above were
analyzed in day 3 embryos in order to determine if differences in gene expression were
influenced by oxygen concentration during in vitro embryo culture. We found no significant
differences in gene expression for any of the five genes of interest between low and high O2
concentration (Figure 16 and Table 10). Due to the low number of embryos analyzed (Table 10)
in each group, we agree these data are not conclusive. However, we propose that the paucity of
differences between the low and high oxygen culture conditions may be due to the fact that all of
these embryos were inseminated under high O2, and only split into different O2 treatments 14-16
hours post insemination. We propose future studies in which cohorts of oocytes are randomly
split into low or high O2 groups, inseminated and cultured to blastocyst stage of development and
then analyzed for the same genes analyzed here.

We predict that non-physiological O2

concentrations (20% O2) will negatively impact mitochondrial dynamics gene expression in
blastocysts. The blastocyst stage of development is the first formation of two distinct cell lines,
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the ICM and the trophectoderm, as well as the time of mitochondrial replication and transcription
in most species. Clearly, this is an extremely important stage of development. The impact of
mitochondria at this stage has been well established; however, the exact role played by
mitochondrial dynamics and movement has yet to be determined.
Additionally, with the inclusion of similar gene expression data collected in our
laboratory from MII oocytes, we have been able compile gene expression levels from three
distinct time point in preimplantation development. For the first time, we are able to show that
expression of genes involved in the control of mitochondrial fusion, fission, movement and
replication fluctuates during preimplantation development in NHP, depending upon the stage of
development. In the MII oocyte, gene expression is at basal levels for all genes analyzed except
for Pink1 (Table 11), while in the zygote, all genes increase 2-3 fold from levels seen in the
oocyte (Table 11). By day 3 of embryo development, Drp1, Miro1 and SSBP1 levels have
decreased, but remain significantly higher than those seen in the oocyte, but also significantly
lower than what is seen in the zygote. There were no significant differences observed for Mfn2
between the oocyte and embryo time points. Interestingly, Pink1, a serine–threonine kinase that
localizes to the outer mitochondrial membrane that has a role in cellular protection against
oxidative stress, was actually statistically higher in the oocyte than in the day 3 embryo. The
reason for this expression level in the oocyte is unknown. These data show that throughout
preimplantation development, certain time points are metabolically quiet (oocyte and day 3
embryo), while other time points require dramatic increases in metabolism (zygote). It is likely
that increased ATP is needed in order to meet the energetic demands of the embryo for the
processes occurring during these developmental stages (i.e. PN formation, polar body extrusion,
syngamy and perhaps even mitochondrial replication, as discussed in Specific Aim 1). Future
studies that will determine gene expression in the blastocyst will be of great importance in
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establishing a true profile of mitochondrial metabolic activity during preimplantation
development.
Interestingly, in both zygotes and day 3 embryos, there emerged a subset of samples with
dramatically higher expression of all genes (Figure 18). As shown in Table 12, expression levels
of these samples can exceed two and even three standard deviations beyond the mean of the total
cohort. The subpopulation is not revealed in the oocyte, however, these samples were not from
the same group of animals used for the zygote and embryo studies and the quality of the oocytes
analyzed is questionable. Through the use of exogenous gonadotrophin stimulation, oocytes that
would have normally become atretic in monovulatory species such as humans and NHPs actually
become dominant follicles due to the excess FSH available. While these oocytes may reach MII
status and ovulate, the quality of these oocytes is suspect. As discussed in Chapter 1, there is not
a benchmark method of identifying poor or good quality oocytes based on anything besides
morphology assessment by the embryologist and the achievement of MII. Furthermore, poor or
bad embryos can be identified based upon morphology and embryonic arrest during the cleavage
stages; however, it remains difficult to identify a high quality embryo based upon anything
beyond development rate and morphological quality score. We propose the subpopulation of
zygotes and embryos seen in Figure 18 and Table 12 were derived from oocytes that were of the
highest quality and naturally selected for ovulation. The dramatically higher levels of gene
expression is not seen in all samples because cohorts are largely comprised of lower quality
oocytes, zygotes and embryos. This hypothesis is supported by human IVF data from 2007 that
revealed only 39.6% of cycles performed resulted in a live birth with an average of 2.2 embryos
used per transfer (2007 SART National Summary). While the number of embryos produced was
not revealed in the SART data report, there were most certainly a significantly larger number of
embryos produced that arrested at some point during development, indicating that a
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subpopulation of embryos were likely of much higher quality than the majority of the cohort.
Furthermore, as previously discussed, a high proportion of genetically abnormal mitochondria in
the oocyte can potentially reduce the number of functional mitochondria, leading to embryonic
arrest and failed implantation.

We believe this hypothesis to be true as seen by the low

expression of genes involved in mitochondrial dynamics, movement and replication in the
majority of the samples analyzed. Further analysis of a larger sample size for all time points, as
well as other critical time points in preimplantation development (blastocyst), will likely reveal
even further the impact of mitochondria on preimplantation development.
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CHAPTER 7
CONCLUSION
The central goals of this study were to evaluate mitochondria in NHP oocytes and
embryos, to determine how mtDNA mutations and mitochondrial function affect oocyte and
embryo quality and to establish the rhesus macaque as an excellent comparative model to study
preimplantation development in the human. The major topics addressed in this dissertation were:
•

determine if there is a large mitochondrial mutation present in the rhesus macaque similar
to the common deletion (mtDNA4977) seen in humans

•

determine if mature oocytes and IVF produced embryos from gonadotrophin stimulated
rhesus macaques harbor a higher proportion of specific mtDNA mutations than immature
oocytes from non-stimulated monkeys

•

determine if the rhesus common mutation is present in in vitro and in in vivo derived
embryonic stem cell lines, as well as adult stem cell lines

•

determine if polymorphisms in the mtDNA control region as well as polymorphisms in
the mtDNA repair mechanism, PolG, are associated with aging

•

determine if failure of oocytes to reach maturity is due to specific polymorphisms in the
mtDNA control region

•

determine if mtDNA control region sequence differences exist between embryos

•

determine how to improve gonadotrophin stimulation methods and IVF efficiency at the
Caribbean Primate Research Center

•

determine if, during syngamy, expression of genes involved in mitochondrial dynamics,
transport and replication are influenced by meiotic stage of gonadotrophin stimulated
oocytes at the time of collection

•

determine if expression of genes involved in mitochondrial dynamics, transport and
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replication are influenced by mitochondrial distribution during syngamy
•

determine expression profiles of genes involved in mitochondrial dynamics, transport and
replication during syngamy and early embryo development
We determined that the rhesus common deletion entails the loss of 5703 base pairs,

which is considerably larger than the 4977 bp common deletion typically found in humans.
Using the same experimental strategy we found that the rate of detection of the rhesus common
mutation in immature GV oocytes was dramatically lower when compared with gonadotrophinstimulated MII oocytes and embryos (Chapter 2). It has been suggested that there is a massive
amplification of the mitochondrial genome during the process of oogenesis, presumably to
support the initial period of embryonic development, and that mitochondrial replication occurs
during a very short period of time from the 1-to 2-cell stage in the mouse embryo prior to
fertilization (McConnell and Petrie, 2004).

Our data, as well as others’, indicates that a

mitochondrial replication event may occur during either exogenous gonadotrophin stimulation,
and/or during oocyte maturation (Chapter 2).
Once we had established that there is, in fact, a rhesus common deletion and that this
deletion is present in both mature oocytes and IVF embryos, we felt it important to determine if
this mutation potentially persists into ESC lines derived from IVF produced embryos. This was
the first study to examine mtDNA mutations in embryonic and adult NHP stem cell lines and we
determined that the rhesus common deletion is present in adult and ES cells from fertile rhesus
macaques. In conjunction with Chapter 2 we have shown that oocytes and embryos from
gonadotrophin stimulated monkeys contain mitochondrial deletions, which carry into ES cell
derivatives. Furthermore, we have shown that adult stem cell lines harbor high levels of the
rhesus mtDNA common deletion, regardless of passage, as well as ESC derived from both in
vivo and in vitro produced rhesus embryo (Chapter 3).
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We agree that further studies that both characterize other mutations that may have
occurred in conjunction with the rhesus common mutation in oocytes and embryos, as well
exploring the mechanisms behind the transfer of mutations from the embryo to ESC, should have
been performed. However, immediately following the data collection and analysis used in the
two publications that became Specific Aim 1 and 2, Hurricane Katrina ravaged New Orleans, as
well as the University of New Orleans, and all material collected for further analyses was
destroyed.

It eventually became imperative for our laboratory to relocate to Wayne State

University.

During that time, the field of determining mitochondrial impact on primate

development changed dramatically and we were no longer in collaboration with Tulane Primate
Research Center, the provider of all the material used in Specific Aim 1 and 2. Upon becoming
reestablished at WSU, we began to focus primarily on the original specific aims described in the
RO1 research grant written by Carol Brenner and Barry Bavister, R01-HD045966-01: Defects in
Mitochondria Impacting Primate Oocyte Quality. The specific aims of this grant were: to
determine the frequency and percentage of mtDNA deletions in primate oocytes and early
embryos, and to determine the localization of active mitochondria in primate oocytes and early
embryos, measure the activity of these mitochondria, and correlate these measurements with
oocyte competence. Previous studies involving aging effects of mitochondria on oocytes were
also included in the direction taken with experiments at that time.

Therefore, it became

important that we proceed in two directions in order to encompass previous work performed by
our laboratory; aging and preimplantation development. In Specific Aim 3, we set out to
determine; 1) if there were mutations in the mtDNA control region associated with the aging
phenomenon, 2) if there were mutations in particular regions of interest within the mitochondrial
polymerase, PolG, associated with aging, and 3) if there were mutations in the mtDNA control
region associated with failure of oocytes to resume meiosis prior to fertilization. We found no
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correlation between aging or failure of meiotic resumption prior to fertilization with mutations in
either the mitochondrial control region or the only known mitochondrial polymerase, PolG
(Chapter 4). While it is clear that mtDNA damage and repair mechanisms most certainly have
an impact on mitochondrial replication and transcription in skeletal muscle and other postmitotic tissues, other factors must be contributing to oocyte and embryo quality and
preimplantation development.
Therefore, in order to improve the quality of oocyte and embryonic material used for
further analyses, we began onsite collaborations with the Caribbean Primate Research Center.
Through improvements made to the existing gonadotrophin stimulation regimens used at the
CPRC, involving the reduction of total rFSH used per stimulation cycle, the addition of rLH to
all cycles and the use of biological hCG in lieu of recombinant hCG, we were able to
dramatically improve the number of MII oocytes collected as well as significantly reduced the
number of unusable GV oocytes collected, as well as reducing the hormone cost of every cycle
by reducing the dose of FSH by half, without any reduction in the number or quality of oocytes
collected (Chapter 5).
With improvements made to the rhesus macaque IVF cycles, and the collection of
reliable, quality material, we have been able to correlate, for the first time, expression of genes
involved in mitochondrial dynamics and movement, as well as mtDNA replication, with specific
time points in preimplantation development that have been previously shown to be important in
mitochondrial activity. Unfortunately, due to the limitations of equipment available at the
CPRC, we were not able to correlate mitochondrial movement and localization with expression
analysis of genes involved in mitochondrial dynamics and movement. However, we do believe
these processes to be linked and future studies employing confocal microscopy have been
proposed for correlation.

We have shown that while critically involved in chromosomal
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normality and stability (Dupont et al., 2009), oocyte maturation from the time of collection (3334 hrs post hCG) to the time of insemination (37-38 hrs post hCG) does not influence the
mitochondrial contribution to the processes of fertilization and syngamy. Furthermore, we have
shown the processes of mitochondrial fusion, fission, movement and transcription are all strongly
associated with each other throughout critical time points of preimplantation development
(Chapter 6).
We determined that embryos inseminated under high O2, and then split into either low or
high in vitro O2 conditions after fertilization exhibited no differences in levels of gene expression
(Chapter 6). In conjunction with the high levels of gene expression seen in zygotes at the time of
syngamy, these data indicate that oxygen concentration conditions may influence embryo culture
at an earlier time point than day 3, namely during fertilization and syngamy when there is a
higher metabolic demand for ATP. We propose other time points of high metabolic demand
(blastocyst stage) may also be influenced by oxygen concentration during in vitro culture.
Similar studies where oocytes are fertilized under either low or high O2 concentration have been
proposed in order to determine at what point oxygen tension becomes critical.
Furthermore, not only have we been able to show, for the first time, that expression of
genes involved in the control of mitochondrial fusion, fission, movement and replication
fluctuates depending upon the stage of development; but that a subpopulation of high quality
oocytes, zygotes and embryos may be identified based upon level of mitochondrial fusion,
fission movement and replication gene expression (Chapter 6)
Due to the ethical limitation of using human oocytes and embryos for invasive studies,
we have shown here that the rhesus macaque is an excellent model used in lieu of human
material. Destructive analyses used in these studies will likely never be allowed to be employed
on human material. Without the use of clinically translational models, such as the rhesus
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macaque, the methods used to determine why fertility and reproductive problems exist as well as
methods to identify, prevent and treat issues and diseases related to fertility and mitochondria,
would be profoundly inadequate.
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Assisted Reproduction Technologies (ART) have been used to treat infertility since 1790.
In the centuries following, dramatic advances have been made in the field of infertility research
through the employment of a variety of species. Despite these advances, determination of oocyte
and embryo quality remains largely subjective. Ascertainment of methods to measure oocyte
and embryo quality to improve selection in ART clinics and increase pregnancy success rates is
imperative. These methods are only possible with a more comprehensive understanding of the
cellular and molecular properties of oocytes and preimplantation embryos. A key component of
all cells, including oocytes and embryos, is the mitochondrion, which produces energy and
maintains its own DNA for encoding proteins necessary for energy production. Defects in either
the proteins responsible for energy production, the mitochondrial DNA (mtDNA) genome, or
other contributing factors can lead to loss of oocyte competence and embryo quality. Human
oocytes and embryos would be the optimal material to use for performing studies on
preimplantation development. However, practical and ethical constraints prevent the use of
human material for intensive, potentially terminal studies; thus, compelling researchers to find
and use suitable animal models instead. The non-human primate (NHP) is the most befitting
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animal model for human reproduction due to evolutionary closeness and the dramatic similarities
in reproductive function and preimplantation development. Furthermore, because studies in
human preimplantation development are restricted to the use of discarded oocytes from infertility
clinics, the use of the NHP has established the rhesus macaque as an excellent research model for
human reproduction due to the availability of normal, viable oocytes and embryos from fertile
animals. Therefore, the overall goals of this study were to evaluate mitochondria in NHP
oocytes and embryos and to determine how mtDNA mutations and mitochondrial function affect
oocyte and embryo quality.
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